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B.A., JILIN
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UNIVERSITY OF MASSACHUSETTS AMHERST

Ph.D.,

UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor David A. Tirrell

Natural proteins
activity

and

(e.g.,

enzymes and

antibodies) perform versatile functions with high

however, are limited because of

specificity. Their applications,

their

poor

material properties. Novel biocatalytic materials are proposed to combine materials
properties with biological functions. Synthesis, assembly and application of a class of

such materials are presented in

Hybrid

artificial proteins,

this dissertation.

with

artificial

produced as "sticky enzymes" where the
natural

domain performs

polypeptides fused with natural proteins, are

artificial

The

catalytic functions.

repetitive polypeptides with sequence motifs

ProGlu).

The

natural

domain

is

artificial

to surfaces while the

domains are a family of

-[-(AlaGly)xZGly-]-n (Z = Glu or

a bacterial phosphotriesterase which catalyzes rapid

hydrolysis of organophosphorus pesticides.

recombinant

domain binds

The

target proteins are constructed via

DNA technology and expressed in Escherichia coli.

molecular weights varied from 55

65 kDa, exhibit

to

All the hybrids, with

catalytic activity for hydrolysis of

paraoxon. The hybrid containing [(AlaGly)3ProGluGly]i6 exhibits Michaelis-Menten
constants of

Km =

120 ptM and

kcat

= 2500

cationic microsphere resins, yielding

form.

72%

s-i.

The immobilized hybrid

relative activity

compared with

is

adsorbed on

the soluble

A column reactor containing the immobilized hybrid showed rapid hydrolysis of

paraoxon.

vii

In a related investigation, a recombinant phosphotriesterase with six consecutive
histidine residues at the N-terminus is produced in E.coli

purified

by metal chelate

Km of

a kcat of 3880

S"^

microspheres

at

shows higher

stability

and

affinity

The recombinant enzyme,

chromatography, catalyzes hydrolysis of paraoxon with

150 |iM. The enzyme

34 units/mg and exhibits

compared

.

kcat of

to the soluble

is

3490

immobilized on non-porous
s-^.

silica

The immobilized enzyme

enzyme.

A flow injection analysis device using immobilized recombinant phosphotriesterase as
enzyme

reactor has been constructed. Paraoxon in aqueous solutions

low detection

limit (5 ng/ml),

wide

linear range (25 to 25(X) ng/ml),

was determined

at

good precision

(R.S.D.= 0,7-5,8%) and sample frequency of 24 samples per hour. The proposed

method, by virtue of

its

an alternative analytical

simplicity, sensitivity
tool for rapid

and

specificity, provides

good

and easy detection of organophosphate

viii

potential as
pesticides.
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CHAPTER

1

INTRODUCTION

1.1

Motivation

In the early 1980s,

hardly

known

little

more than

a decade ago, the term "genetic engineering"

was

outside the research laboratory. However, in the few short
years since

they appeared, the

first fruits

implanted with a foreign

of genetic engineering—products

gene— have contributed handsomely

made by organisms

to

human

welfare. Large

quantities of previously scarce therapeutic proteins are produced through
genetic

engineering,

among which

are insulin,

human growth hormone, and

tissue-plasminogen

activator (or t-PA). In 1989 genetic engineering products were selected as one of the
ten

outstanding engineering achievements by the National
the past 25 years, along with the
is

commonly recognized

moon

Academy of Engineering

landing and computation technology I

during

By now,

it

that genetic engineering has the potential to revolutionize

medicine, agriculture, and the environmental industry, and to change our lives more than

perhaps any other scientific or technological advance.

From

a polymer science point of view, genetic engineering provides excellent

opportunities to produce polymers with well-defined molecular architecture, something
that conventional

polymerization

polymer synthesis has not been able

—chemical

synthesis

—

methods

Conventional

are statistical processes, resulting in

polymeric materials

that are mixtures characterized

Although enormous

efforts

have been devoted

to accomplish.

to

by

substantial molecular heterogeneity.

develop synthetic methods to give

controlled molecular architecture, there has not been a method to date where sequence,

molecular

size,

molecular weight distribution and stereochemistry of polymers can be

absolutely controlled at the

same

time.

On

the other hand, biological synthesis of proteins

1

involves template synthesis of messenger
(transcription) followed
(translation).

to

by production of the protein from the

mRNA template

Such biological synthesis machinery allows enormous amounts of proteins

be synthesized precisely according

activities.

RNA from the DNA containing the gene

to

DNA information, to support our everyday

Inspired by the accuracy and efficiency of nature, our research group has

applied the principles of protein expression to explore biological synthesis of polymeric
materials^. In addition to precise control of molecular architecture, biological synthesis

usually takes place at

room temperature under normal

pressure and produces

biodegradable waste, in contrast to chemical processes that often involve high temperature

and pressure. The biological synthesis of polymeric materials has been
advances

in

recombinant

synthesizer to produce

realized

by

DNA technologies, including the availability of the DNA

artificial

genes readily. Through genetic engineering, polymers

with precisely controlled molecular architecture were synthesized, to form well-defined
crystalline lamellae-', novel liquid crystal phases'*

and surface

functionality.

Given the success of design and synthesis of polymeric materials with defined
structural properties

and surface functions, we have explored the capacity of genetic

engineering to combine materials properties with biological functions derived from natural
proteins. Natural proteins have evolved over billions of years to perform particular

biological functions,

most of them with bewilderingly high

activity

and

specificity.

Yet

natural proteins are pooriy defined materials for applications. Proteins in solution are

hard to use in continuous operational processes;
activity in a short period of time;
difficult, thus

making

natural proteins

proteins are unstable and lose

and recovery of proteins from the reaction product

is

the operation costly. Incorporation of materials properties into

would allow

particles, surfaces,

many

scientists to harvest biological functions in the

and membranes. The motivation of

this thesis

work

is

forms of

therefore, via

materials and
genetic engineering, to provide simple routes to produce biocatalytic

background and
assembly of biocatalytic surfaces. Chapter one introduces a general

2

current review of research fields involved in the
thesis work. Chapter two describes
one

approach to give materials properties
artificial

to natural proteins,

demonstrated by fusion of an

polypeptide with an enzyme. Chapter three reports engineering
of a natural

enzyme by immobilization on

a solid support with retention of high enzymatic
activity.

Chapter four exhibits an application of the immobilized enzyme

in a biosensor device for

continuous detection of organophosphate pesticides.

1

Protein Engineering

.2

1.2.1

Design

Nature has evolved over billions of years

which fold

into a variety of structures

stability,

enormous number of proteins,

and cairy out a diversity of functions. Studying

and manipulating natural proteins has lead

thermodynamic

to provide an

scientists to

understand their folding pathways,

and catalytic properties. Such understanding

is

enhanced and

ultimately tested by the ability to design systems to achieve desired structures and
functions, with goal of eventually producing novel macromolecules that will be

"made

to

order" for solving important chemical and biochemical problems and having applications

ranging from industrial catalysis to biomedical engineering.

approaches have been pursued

in novel protein design:

modification and improvement of their functions,
entirely de novo.

Here we

will give a brief

(ii)

(i)

Two very different

engineering natural proteins for

designing functional proteins

summary of recent advances with

approaches, with emphasis on fields related to the thesis work.

3

both

1.2.2 Engineering of Natural Proteins

Many

natural proteins comprise structural scaffolds
that are quite robust and tolerant

of a wide variety of sequence modifications^.

have made

it

Modem

genetic engineering procedures

possible to produce natural proteins in large quantities,
and to modify their

primary structures, with concomitant control of physico-chemical
and biological
characteristics^.

As

a result,

it is

possible to tinker with natural structures and thereby

engineer proteins with modified specificity and

(I)

activity.

Alteration of Properties of Natural Proteins

Natural proteins have been engineered to exhibit
activities).

new

functions (such as catalytic

A very powerful and widely applicable approach is the design of catalytic

antibodies^.

Lemer and coworkers explored

the antibody's tolerance of enormous

variation of hypervariable loops with corresponding binding specificity^.

By

using

antigens (haptens) that resemble the transition state of a reaction, antibodies can be raised
to catalyze the reaction

state

by

specific binding

and

stabilizing the rate-determined transition

on the reaction pathway. Hundreds of catalytic antibodies have been developed

catalysis of a variety of chemical reactions,

some

for

which no natural enzyme

Antibodies have been produced to catalyze hydrolysis of phosphate

amine oxide hapten

to

mimic

triesters

known.

by use of an

the electrostatic features of the transition state^.

enhancement of 10^ was observed

is

A rate

for catalytic hydrolysis of a phosphate triester

by the

antibody.

Enzymatic

catalysts are of significant industrial interest because they are able to

perform complex chemistry

commercial

use,

efficiently

and because they are biodegradable. Their

however, has been limited because they are often too

conditions of commercial manufacturing processes. Recendy, a

4

for

fragile

under

new technology was

developed by

scientists at Altus

Biology (Cambridge,

cross-linking (with glutaraldehyde, etc.)

enzymes

to

MA) of crystallizing and chemically

produce stable heterologous catalysts

from crude protein mixtures. The cross-linked enzyme

crystals

activity while gaining thermal stability, conformational stability

degradation.

It is

(CLECs)

retain catalytic

and reduced proteolytic

reported that the resulting products can withstand extremes of pH,

temperature (above 50 °C), and use

in

organic solvents^. The stability of CLECs

may be

a result of the crystalline nature of the material, combined with the covalent cross-linking

of the enzyme molecules.
solutions^ ^

and

CLECs

are being explored for applications in aqueous

in organic solvents^ ^'

In recent years there has been

much

interest in

the use of enzymes as catalysts in organic syntheses and polymerization'^. However, the
synthetic potential of enzymes has been limited by the low activity of enzymes in organic
solvents, in large part
lyophilization^'*.

due

to

CLECs, on

conformational changes that occur upon dehydration with
the other hand, are solid crystalline particles that are

insoluble in aqueous and organic solvents and

compared
5

to the

"amorphous" enzymes

in

show

superior catalytic activity as

anhydrous organic medium'^. So

far there are

CLEC catalysts that have been produced in multi-kilogram scale and commercialized by

Altus Biologies^. The company has recently received a contract from the Department of

Defense

to

produce cross-linked enzyme crystals of phosphotriesterase from

Pseudomonas diminuta

(II)

for neutralization of nerve gas'^.

Recombination of Properties of Natural Proteins

Besides modifications of natural proteins through changes of small amount of
residues as mentioned above, another approach to give novel function

rearrangement of natural proteins

to

combine properties from

by

different proteins and,

ultimately, to execute multiple functions in a single polypeptide.

5

is

Proteins that exhibit two biological functions
on a single polypeptide chain exist in
nature, with different functions carried out by
different domains.

Such combinations not

only promote optimal performance of the protein but
also allow efficient production of a
variety of polypeptide chains from limited genetic
constructs. Antibodies, as the

of defense against bacterial and

viral infection,

first line

have been shown to carry Fv and Fab

fragments as antigen-binding domains and Fc fragments as effector
domains triggering
elimination of the antigen^*^.

enormous

One of the

diversity of antibodies arises

elements of the antibody genes.
essential in

A

muscle contraction and

globular head fragment (SI)

at the

important mechanisms accounting for the

from recombinatorial arrangements of the domain

second example

is

provided by myosin, which

cell division in eukaryotic cells.

N-terminus that binds

to actin,

Myosin

is

consists of a

and a fibrous

light

chain fragment that serves to interact between the actin filaments^ ^. Chicken myosin
containing two different light chains
transcriptions and

With

RNA

is

derived from a single gene by two different

processings^.

the advance of molecular biology, fusion proteins can be readily produced by

ligation of genes encoding different proteins or domains.
in

many

The

resulting fusion proteins,

cases, exhibit the individual biological activities of each protein domain. Fusion

proteins have been used to facilitate recombinant protein expression in heterologous

—

hosts. Reporter

enzymes

been fused with

target proteins for increased stability^^, ease of detection^^

proteins with

secretion^^. Fusion genes encoding

used in

affinity

chromatography

good expression

domains

levels

—have

and easy assays

and protein

that recognize specific ligands are

to assist purification of

widely

recombinant proteins^^*

Monoclonal antibodies have been genetically engineered and endowed with new
properties'^. Therapeutic antibodies are

made by

fusing gene segments encoding

antigen-binding domains (Fv or Fab fragments) to genes encoding toxins^^ and

enzymes^^. The engineered antibodies can target toxins or enzymes to specific types of
cells.

Another example

is

immunoadhesins

in
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which a ligand

specific for a cell-surface

receptor

with

is

HIV

attached to an Fc fragment.

and

kills the cells

The

protein binds to the surface of cells infected

by antibody-dependent cell-mediated

cytolysis^"^.

Genes encoding subunits from a complex enzyme have been fused together to
produce fusion proteins

to elucidate the structure-property relationships of

enzyme

complexes^^. Genes encoding enzymes that are involved in sequential reactions have

The product of the reaction catalyzed by

also been joined.

substrate of the second

enzyme domain. The

the first

fusion protein

enzyme

was used

serves as the

as a conceptual

"chain reaction channel" to achieve higher reaction efficiency^^.

Genetically engineered affinity domains were fused to proteins of interest to

enzyme

facilitate

Such fusion proteins could be immobilized by taking

immobilization^"^-

advantage of the specific binding of the

affinity peptide to

an affinity adsorbent, while the

partner domain exhibits biological activity on the surfaces^^'
the purification and immobilization can be

done

recognition processes drawn from nature,

e.g.,

in a single step

Of those

fusion proteins

through the specific

antibody-antigen, enzyme-substrate or

receptor-ligand interactions. This fusion protein approach allows immobilization of

enzyme without
The

first

denaturation and with retention of high catalytic activity.

report of a genetically engineered fusion protein for

fusion between the gene (abg) for a P-glucosidase (Abg) of an

was constructed by
Agrobacterium
fimi

Cex and

The

sp.

enzyme immobilization

and part of the gene (cex) for an exoglucanase (Cex) of Cellulomonas

fusion protein

(Abg-CBDcex) exhibited

(3-glucosidase activity of

glucosidase activity

when bound

the cellulose-binding properties of

Abg. The fusion protein retained

to cellulose.

The binding was

42%

stable

of its p-

enough

to allow

continuous hydrolysis of substrate by the enzyme without detectable leaching of the

enzyme from

CBD/RGD

the cellulose. Recently, the

same research group reported fusion of

as a linking molecule between a cell

and a cellulose

surface^^.

The sequence

such as fibronectin, collagen, and

Arg-Gly-Asp (RGD)

in extracellular matrix proteins

laminin mediates

cell
attachment by interacting with proteins of the integrin family of

cell
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surface receptors.

The

fusion protein containing the

RGD peptide fused to the C-

terminus of CBD domain promoted the attachment of mammaUan

monkey Vero cells,
Protein

to polystyrene

and cellulose

cells,

such as green

acetate.

A from Staphylococcus aureus (SpA) is a receptor for the Fc domain of

several classes of antibodies including

immobilization.

immunoglobin (IgG) and has been used

A hybrid protein consisting of protein A and the enzyme

was adsorbed on IgG-coated Sepharose

Km relative to covalentiy immobilized

P-lactamase. Adsorption of the hybrid protein on

Kondo and coworkers who used

domains of protein

p-lactamase

matrices^"* with higher specific activity and lower

the support resulted in increased stability to thermal deactivation.

reported by

for protein

"affinity tag

AG"

A similar approach was

consisting of IgG-binding

A and those of protein G from Streptococcus strain G 148 to faciUtate

immobilization of P-galactosidase-'^. AG^gal retained approximately

upon immobilization and

the binding

was

Hentz and coworkers described an
protein which contained calmodulin

stable

affinity

enough

75%

to allow repeated use.

chromatography system using a fusion

(CaM) and

protein

A (ProtA)^^, exploring the

molecular recognition properties of the two components of the fusion. In
serves as the anchoring component by virtue of

phenothiazine. Thus, the

of its activity

its

particular,

binding properties toward

ProtA-CaM can be immobilized on

a solid support containing

phenothiazine from the C-terminal domain of the fusion protein, while Protein

terminus serves as the affinity

site for

upon addition of ATP under mild

DnaK (a heat

conditions.

The

CaM

shock protein).

affinity

DnaK

is

A at the N-

released

column can be regenerated by

removal of the immobilized fusion with addition of EGTA and reloading of fresh ProtA-

CaM.

An oligopeptide containing multiple histidines was
chelating columns charged with

His-Gly-His-Arg-Pro was fused

Zn

ion^^.

to the

used for protein immobilization on

The polypeptide with

repeating sequence Ala-

N-terminus of p-galactosidase and to the C-

could be
terminus of a synthetic IgG-binding protein. Relatively strong interaction
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observed for the fusion based on four or eight repeating
units of the
fusion proteins were found to be eluted from the
resin at different

number of repeats. More

recently, Hochuli and

affinity peptide.

pH

The

depending on the

coworkers used N-terminal hexahistidine

fusion proteins to immobilize p-galactosidase to a
Ni2+-nitrilotriacctic acid adsorbent^^.

The

fusion protein retained

64%

of

its

p-galactosidase activity

adsorbent. Allyl-p-D-galactopyranoside

on a gram

scale

when bound

was synthesized from

to the

lactose and allyl alcohol

by the immobilized p-galactosidase.

Fusion proteins containing polyionic peptides were reported as

tool to

produce

immobilized enzyme catalysts^l Enzyme immobilization was realized through
a fusion
protein of yeast a-glucosidase containing at

its

C-terminus a polycationic hexaarginine

fusion peptide. This fusion protein can be directly adsorbed from crude
cell extracts on

polyanionic matrices.

Upon

immobilization, the stability of the fusion protein

affected by pH, urea, or thermal denaturation.

influenced by this noncovalent coupling.

The enzymatic

is

not

properties are not

The immobilized enzyme was used

in a

column

reactor for production of carbohydrates with good operational stability.

1.2.3

Engineering of Artificial Proteins

Perhaps the more adventurous step

in protein

protein with novel functions. Designing

new

engineering

proteins

is

to create completely

from scratch

accumulated knowledge of protein structures and functions

—

— based on

new

the

takes an active approach in

understanding nature, and very possibly would open a wide range of new applications.

Many de novo
such as helical

macromolecules

proteins have been produced that fold into predetermined structures'^*
bundles'*^^*'*'.

Moreover, the goal of protein design

that possess interesting

is

to

produce novel

and useful functions. Most attempts

at the

design of function have focused on binding and/or catalysis. Proteins have been

produced

that contain metal binding sites,

mostly Zn(II) and Cu(II), either by reproducing

9

the geometry and associated structural and catalytic properties of
natural sites or by

completely

new

metal binding

design'*^

sites in

Case constructed a
site for

y^^^

which Zn

^^^^^^ four-helix bundles
(II)

was bound with

to incorporate

K<i of 2.5 x 10 "8 M"*^. Ghadiri

and

three-helix bundle that has a binding site for Ru(II) at one end and a

Cu(II) at the other^.

The

synthetic protein

with each metal binding specifically to
three peptides and

were modified

two metal ions

its

designed

was shown
site,

to

bind both metal ions

directing the self-assembly of the

into a unique heterodinuclear metalloprotein.

Polypeptides of extremely hydrophobic sequence were designed to bind the insecticide

DDT*^, with

M.

dissociation constant of 9 x 10

Design of catalytically active proteins has remained a challenging

Chymohelizyme used by Hahn and coworker was designed
specificity similar to chymotrypsin"*^.

was designed

topic.

The

as an esterase with a

The Helichrome employed by Sasaki and Kaiser

as an aniline hydroxylase"*^

.

The helichrome exhibited

activity similar to

those of natural proteins such as hemoglobin for hydroxylating aniline. Both designed
catalytic sites

were based on

sites

found

in natural proteins

the structure and position of the binding pockets.

coworkers designed a novel enzyme
with the active

site

On

and crosslinked

the other hand,

to preorganize

Benner and

that catalyzes the decarboxylation of oxaloacetate

designed from scratch. The kcat of the synthetic peptide was 5 orders

of magnitude lower than that of the natural enzyme but

still

around 900 fold larger than

the rate constant of the uncatalysed reaction"*^.

Novel peptides have been designed

to self-assemble into

new

materials. Ghadiri

and

coworker designed a peptide of sequence cyclo[-(D-Ala-Glu-D-Ala-Gln)2], which adopts
a

flat

flat

ring conformation.

At low pH,

the intermolecular hydrogen bonding between the

rings forces spontaneous self-assembly of the peptide into long hollow tubes

nanometers long and the internal diameters are dictated by
peptide^^'^o.
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the size of the cyclic

1.2.4 Protein-Based Polymeric Materials

Many naturally

occurring structural proteins such as

silk, elastin

and collagen show

properties that fascinate materials scientists. For example,
dragline silk exhibits both
tensile strength

and extent of elongation superior

synthetic fibers^ ^

The sequences of many

highly repetitive amino acids.

to that of other

high-performance

structural proteins contain long stretches of

A variety of polymeric proteins are produced based on

sequences of naturally occurring structural proteins^l

developed by Urry and coworkers

that

Among those

expand and contract

are polypeptides

in response to pH^^- 53

polymers contain the repeating sequence (Val-Pro-Gly-X-Gly), where
a ratio of 4: 1. At neutral
the polymer.

When

the

pH the

X is Val or Glu at

glutamic acid residues are charged, causing expansion of

pH is lowered

to 3, the

COOH, resulting in collapse and contraction

Glu

side chains are converted to neutral

of the polymer. Through such mechano-

chemical coupling, the polymer was able to pick up weights 1000 times greater than

of the polymer

Over

-phe

that

itself.

the last ten years or so, our research group has produced de novo protein-based

polymers

to achieve well-defined

produced

to

molecular architecture. Uniform polymer chains are

answer important fundamental questions

(e.g.,

lamellar crystal formation,

alignment of liquid crystals) and assembly into new polymeric materials^^. The design of
the sequences of such polymers

polymer chemistry and

is

based on concepts and observations from both

structural biology.

The

first artificial

polypeptides contained

repeating sequences of [(AlaGly)3ProGluGly]^'^. The protein-based polymer was

expected to form lamellar crystal structures, with the AlaGly

triads

forming extended P-

sheet and ProGlu residues initiating the chain folding. Artificial genes encoding the

monomeric

units

polymerized into
corresponding

were synthesized by

solid state chemical synthesis

and enzymatically

DNA multimers, which served as templates to produce the

artificial proteins.

The

resulting proteins didn't
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form

crystal structures as

expected, rather they were shown to be mostly
amorphous structures.
a series of polypeptides designed

later,

with deletion of the proline

folded into lamellar crystals whose thickness

is

difficult to

into the crystal lattice,

fit

in the

the other hand,

sequence,

controlled by the periodicity of the

primary sequence^. Recent evidence has shown

and

On

that the glutamic residues, being

were indeed present on

structures as designed. Currently, efforts have been

bulky

the surface of the

made where

the sequences are

systematically varied to further understand the factors that determine
molecular structure

and supramolecular assembly of polymers

in the solid state.

Furthermore, the scope and

applications of the genetically engineered polymers are expanded by our
success in

incorporating unnatural amino acids into the polypeptides and thereby introducing
functionality that

is

not available with the twenty natural

amino

new

acids.

1.3 Phosphotriesterase

Organophosphate (OP) pesticides have become the
industrial countries in the last fifty years,

due

largest class of pesticides in

to their high effectiveness^^.

However, the

pesticide loses persistence in soil after a period of application. Investigations led to the
isolation of pseudomonas diminuta strain

MG that contained the plasmid-born enzyme

phosphotriesterase(called parathion hydrolase by the authors)^^.

enzyme was

first identified

The gene encoding

and sequenced by Serdar and coworkers

the

in 1989^^.

Subsequently Mulbry and coworkers characterized and sequenced the gene for bacterial
phosphotriesterase from Flavobacteriwn. and showed that the
identical in both cases^^

amino acids

.

The enzyme

prior to cleavage of a

is

DNA

sequences are

translated as a larger precursor protein of

29-amino acid leader peptide from the N-terminus

form the nature enzyme. The gene encoding

cells,

to

the bacterial phosphotriesterase has been

subcloned into a variety of expression vectors^^ and the protein purified
using insect

365

to

Streptomyces Uvidans, and Escherichia coli as hosts^^-

12

homogeneity

Significant improvements in the levels of protein
expression in E. coli have been obtained

by deletion of the 33 N-terminal amino acids and
replacement of the

first

5 lac

Z residues

(Met-Ile-Thr-Asn-Ser-) followed by the enzyme residues
(-Gly-Asp-Arg-)^*.

The

natural substrates of the phospholriesterase are

still

unknown. The enzyme

is

a

highly efficient catalyst for the hydrolysis of an extensive
variety of synthetic
acetylcholinesterase inhibitors, most of which are organophosphorus
pesticides and nerve
agents<^2 (pigure 1.1).

It

catalyzes the hydrolysis of paraoxon (O.O-diethyl-O-/?-

nitrophenyl phosphate)with rate enhancements that approach

mechanism of phosphotriesterase have been

1()12.

The

extensively investigated using

genetic^\ and spectroscopic methods^"^'^, chemical modification and

and X-ray

with eight strands of parallel p-pleated
revealed that the active

site

sheet"^".

kDa

subunits, with an o/p-barrel fold

Subsequent studies of the holoenzyme

contains two equivalents of

cadmium

located at the C-temiinal portion of the (3-barrel.

structure of the Zn2+/Zn2+-substituted
1.2)^-^.

inactivation^''^'^

analysis of the crystal structure of the apoen/.yme revealed that the

phosphotriesterase consists of a honKxiitner cf 39

is

kinetic''^,

diffraction^^'"^^.

The X-ray

the site

structure and

The

ions separated by 3.7 A;

The three-dimensional

enzyme has subsequently been

zinc ions are separated by 3.3

lysine residue (Lys 169) and a hydroxide.

A

reported (Figure

and bridge with ligands of a carbamylated

The

structure of the co-crystallized

complex

with diethyl 4-methylbenzylphosphonate shows that the substrate analog occupies a
near the binuclear metal center, with the phosphoryl oxygen situated 3.3

solvent-exposed zinc ion. The aromatic portion of the inhibitor binds

hydrophobic

pot'ket.

A

electrostatic interactions

striking feature of the active site pocket

between the inhibitor and

the protein,

is

A

site

from the more

in a fairly

the lack of direct

which might explain the

broad substrate specificity exhibited by phosphotriesterase.

The

catalytic reaction

mechanism of the

i)hospholriesterase has been

shown

to

proceed via an SN2-like associative mechanism with activation of a water molecule by the
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metal center, followed by the direct hydrolysis of the
substrate resulting

in

configuration at the phosphorus center and dissociation
of products^- ^4

have indicated

that the rate-determining step

an inversion of

Bronsted plots

changes from hydrolysis of the P-O bond

a conformational change and/or binding events as the
pKa value of the leaving group
altered^^. 75

is

bond cleavage

state structure; the rate

limited by diffusion of the

enzyme and

roles for each of the

NMR, EPR,

two metal ions

Cd2+, or

The two

Mn2+

native

with the restoration of

in the

is

in catalytic reaction

bound

Zn2+ ions can be

specific activity has been reported in

supplemented

substrate rather than the actual

and X-ray crystallography studies have shown

molecule that attacks the phosphoryl center
center^^'

of hydrolysis with paraoxon

step^^.

The precise
Recent

is

study of structure-reactivity relationships and the solvent viscosity
effect

demonstrated a product-like transition
as a substrate

to

cells

that the water

directly to the binuclear metal

substituted with either Co2+, Ni2+,

full catalytic activity''^.

whole

remain unknown.

when

An enhancement of the

divalent metal ions were

growth medium^^-

Six out of the seven histidines in the

enzyme have been shown

to

be essential

in

substrate binding and catalysis, through studies of site specific mutagenesis of the seven
histidine residues to asparagine^^. Inactivation studies of the phosphotriesterase with

diethyl pyrocarbonate and the

pH rate profiles

phosphotriesterase suggest that an active

for the hydrolysis of paraoxon by the

site histidine

residue acts as the general base or

proton shuttle group^^. X-ray crystallography shows the coupled binuclear metal center
is

embedded within

a cluster of histidine residues^^'

The more

buried zinc ion

surrounded by His 55, His 57, Lys 169, Asp 301, and the bridging hydroxide
trigonal bipyramidal arrangement.

ligated to

The more solvent-exposed

Lys 169, His 201, His 230, and

a working model of the active

site,

as

zinc ion

the bridging hydroxide.

shown

in
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Figure

1.3,

is

is

in a

tetrahedrally

These studies lead

where the metals serve

to

to

polarize the phosphoryl oxygen bond and facilitate the nucleophilic
attack of the metal-

bound hydroxide
Parathion
organisms''^.

is

to give the hydrolysis products.

an organophosphate pesticide

The

utilization

They have

coworkers''^-^^

mixed microbial

extremely toxic to higher

of phosphotriesterase for the enzymatic removal of

parathion from pesticide containers or to clean

Munnecke and

that is

has been demonstrated by

soil spills

studied the degradation of parathion by a

culture and found the major metabolites to be p-nitrophenol (PNP) and

diethylthiophosphoric acid^^. Hydrolysis of parathion reduces

and releases water-soluble metabolites

fold

that are

more

its

toxicity

by nearly 120-

available to further microbial

degradation.

Immobilized forms of the phosphotriesterase for degradation of pesticides have been
described in two studies so

far.

Bacterial cell lysates containing phosphotriesterase were

covalently bound to controlled porous glass ^CPG) and silica (CPS)^^reported relative activities of 3-41

The author

% of the immobilized enzyme depending on the amount

of protein loaded. The maximal relative activity was achieved with only 7 units of

enzyme bound

per grams of porous

phosphotriesterase on
preparation

was found

trityl

to

silica.

Caldwell and coworkers immobilized purified

agarose through physical adsorption^"*. The resulting

have

40% maximal

performance of free soluble enzyme

degrading paraoxon; however, paraoxon and other substrates
the

trityl

agarose matrix. Addition of

10% methanol was

all

showed

affinity

in

toward

required to suppress adsorption

of paraoxon.

1.4

Immobilized Enzymes

The term "immobilized enzymes" was
Engineering Conference held

at

Henniker,

first

adopted

in

1971

New Hampshire,

of E. Katchalski-Katzir^. The definition of immobilized
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at the first

Enzyme

according to the suggestion

enzymes—enzymes

that are

physically confined and localized, with retention
of their activity, and which can be used

repeatedly and continuously^S—also gives a

Compared with

their soluble counterparts,

summary of the advantages of the

system.

immobilized enzymes have considerable

operational advantages, including compatibility with
continuous operations, ease of

product recovery and purification, and readiness for repeated
use. In many cases,

found

that

enzymes gain

stability

it is

with respect to denaturation upon heating and
prolonged

storage in the immobilized form^^*

Immobilized enzymes have served as model

systems for natural, in vivo, membrane-bound enzymes^l Recentiy,
immobilization was
exploited to modify

1.4.1

enzyme

activity^^.

Immobilization Techniques

Enzymes can be immobilized by

a

number of techniques, which can be broadly

classified as follows^^:

(1)

Chemical methods
(i)

Covalent bonding of the enzyme to a derivatized, water-insoluble matrix. The

most widely used coupling agents including glutaraldehyde and carbodiimides. The
advantage

is

formation of a stable enzyme-support complex; disadvantages include

complication of chemical reactions, especially the possibility of reaction with essential
residues for activity and thereby loss of enzymatic activity. For each specific enzyme,

developing a chemical coupling reaction to immobilize the enzyme without loss of

enzymatic activity can be time consuming and
(ii)

Crosslinking, most

diazobenzidine.

bonding

commonly by

The procedure

enzyme and

enzymes.

glutaraldehyde, bi-isocyanate, or bis-

is relatively

results in stable proteins.

difficult for sensitive

simple, and strong intra- and inter-molecular

However, the process requires a

the reaction is difficult to control.
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large

amount of

(2) Physical

(i)

Methods

Adsorption (through hydrogen bonding, ionic interactions,
or hydrophobic

forces). This

method has

the advantage of being simple and mild,
causing less disruption

of the enzyme. However, the linkage

is

highly dependent on pH, solvent and

temperature. There are possibilities of leakage over
extended time of use.
(ii)

Entrapment

in gels or

membranes. This method

requires relatively mild conditions.

At

the

same time

is

universal to

proteins,

all

and

there are large diffusion barriers and

the possibility of enzyme leakage.

1.4.2 Applications of

1.4.2.1

Immobilized Enzymes

Biocatalysts and Bioreactors

Enzymatically catalyzed reactions take place
solutions,

industry,

and

at

room

temperature, in aqueous

normal pressure. Enzymes have been used for centuries

and more

industries^.

at

recentiy,

have found applications

Immobilized enzymes are quite

in the pharmaceutical

stable, often

more

counterparts. These features enable bioengineers to construct
facilitate

in the

food

and chemical

stable than their soluble

enzyme

reactors that

a particular catalytic reaction. Immobilized-enzyme reactors enjoy advantages

such as high enzyme loads, prolonged enzyme
high flow

rate,

activity, the ability to recycle products,

reductions in costs, energy and waste products, easy scale up to large

systems, and high yields of pure materials^^. Currentiy the reactors

in

use include batch-

fed stirred-tank, continuous stirred-tank, continuous packed-bed and fluid-bed reactors^.

Immobilized enzyme reactors have been used
chemical industries. The

first industrial

a

and

use of an immobilized enzyme reactor was

reported in 1967 by Chibata and coworkers

They developed

in the food, pharmaceutical

at

Tanake Seiyaku Company

in

column of immobilized aminoacylase on DEAE-Sephadex
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Japan^l
to resolve

DL-amino

synthetic racemic

acids into optically active

have been extensive research and a steady increase
based on immobilized enzyme reactors^.

Among

L-amino

in the

acids. Since then there

number of industrial processes

these processes

is

immobilized glucose

isomerase, which catalyzes transformation of glucose to fructose. The estimated
world

wide production of high-fructose

com

examples include immobilized lactase
penicillin

from

compound by immobilized

acrylonitrile

from immobilized

syrup was 8 x 10^ tons in 1992^^

qj^^^

in the hydrolysis of lactose in milk^^. production of

penicillin amidase^^;

and synthesis of acrylamide

nitrile hydratase^^.

1.4.2.2 Analytical Applications

Enzymes, with

their

unique specificity for specific substrates, make excellent

candidates for development of analytic systems specific for target analytes. The
attractions of

immobilized enzymes from an analytical standpoint are primarily

reusability, cost reduction,
(e.g., potentially

and the greater efficiency and control of their

their

catalytic activity

longer half-lives, predictable decay rates and more efficient multi-step

reactions) Immobilized

enzymes have been used

in three

forms for analytical

applications.
(1) Solid

phase enzyme reactors, for use

in

continuous flow techniques such as flow

injection analysis and post-column derivatization in liquid chromatography^^.

(2)

Membranes, incorporated

into sensors such as potentiometic

enzyme

electrodes and

optical sensors^^.

photometric detection^^.
(3) Films, for use in disposable, dry reagent knits with

Biosensors comprise biological sensing elements

(e.g.,

enzymes, antibodies,

receptors) in close proximity or integrated with a signal transducer that

is

capable of

providing information on the composition of the surroundings. The emitted signal
(electrochemical, optical or thermal)

is

transmitted to a suitable calibrated recorder. In

18

recent years, there have been important developments

biosensors, such as amperometic and potentiometic

in the

enzyme

design and construction of
electrodes,

enzyme

thermistor devices, field-effect transistor-based biosensors, and fiber-optic sensors based

on bioluminescence and chemiluminescence. All of them employ immobilized enzyme of
various types^^. Biosensors have great potential as useful tools

environmental monitoring, and

in the

in diagnostics,

food industry^^. Reagentless biosensors can be

constructed by co-immobilizing both enzymes and mediators onto a miniaturized electrode

using electropolymerization, thus improving the sensitivity and speed of the response^^*

Recently there are significant efforts devoted to electrochemical sensors,
direct electrical

communication

through conducting polymers.
aniline

is

made from

Certain

and tyramine were polymerized

surface; such conditions also bring

in

which

an redox enzyme to an electrode surface

monomers such

as pyrrole, N-methylpyrrole,

at a sufficiently positively

most proteins

to the surface^^^*

devices of this type could potentially be used as novel "biochips"

networks.
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charged electrode
Electronic

in appropriate
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Figure 1.3 Schematic representation of the postulated catalytic mechanism of
phosphotriesterase^^
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CHAPTER

2

HYBRID ARTIFICIAL PROTEINS: A NOVEL APPROACH TO COMBINING
MATERIALS PROPERTIES AND BIOLOGICAL FUNCTION

2.1 Introduction

Natural proteins

(e.g.,

enzymes and

antibodies) perform versatile biological

functions with high activity and specificity under mild reaction conditions; they are

biodegradable and environmental friendly. Proteins (mostly enzymes) have been used for
centuries in the food industry, and
industries as well^

Modern

produce natural proteins

more

recently, in the pharmaceutical and chemical

genetic engineering procedures have

in large quantities,

and to modify

concomitant control of physico-chemical and biological
is

great

demand

their

made

possible to

it

primary structures, with

characteristics^.

Although there

for protein products, there are limitations as well: proteins in solutions

are hard to use in continuous operations;

many

proteins are unstable and lose activity

within short periods of time; and recovery of proteins from the reaction product can be
difficult (in fact,

Effort to

most bulk enzymes are discarded

overcome these problems includes immobilization of natural

Immobilized enzymes
of their

after a single use).

activity,

—enzymes

that are physically confined

proteins.

and localized, with retention

and which can be used repeatedly and continuously-^

—have considerable

operational advantages compared with free soluble enzymes. Immobilized enzymes are

compatible with continuous operations, easy
repeated use. In

many

cases,

it

is

found

that

to

recover from product, and ready for

enzymes gain

stability

with respect to

denaturation upon heating and prolonged storage in the immobilized form"^'

Immobilized enzymes have served as model systems for

natural, in vivo,

bound enzymes^. Recently, immobilization was exploited

28

to

^.

membrane-

modify enzyme

activity

.

Enzymes can be immobilized by

number of techniques^, including covalent bonding,

a

crosslinking, physical adsorption and entrapment in gels or membranes. Immobilized

enzymes have been used

as heterogeneous biocatalysts in industrial processes^ including

racemic separation^, production of high-fructose
in milk^^.

More

recently, immobilized

com

syrup

and hydrolysis of lactose

enzymes have been applied

in biosensors that are

finding increasing use in medicine, food quality control and environment monitoring^ ^

For each

specific

enzyme, developing an immobilization technique without

enzymatic activity can be time consuming (and

difficult for sensitive

enzymes).

Genetically engineered affinity domains have been fused to proteins to

enzyme immobilization ^2"*'*. Such

domain

facilitate

fusion proteins could be immobilized by taking

advantage of the specific binding of the
partner

loss of

affinity peptide to

exhibits biological activity

on the

an affinity adsorbent, while the

surface^-^'

Such fusions allow

immobilization of enzyme without denaturation and with retention of high catalytic
activity.

With advances

in

recombinant

DNA

technology, fusion proteins have been

made

readily through manipulation of the genes of different proteins, by "cutting and pasting"

of restriction fragments, and subsequently producing target proteins
(mostly in Escherichia

coli).

The

resulting fusion proteins, in

many

in living

organisms

cases, exhibit the

individual biological activities of each protein domain. Fusion proteins thus provide

opportunities for rearrangement of natural proteins to combine properties from different
proteins, and ultimately, to execute multiple functions in a single polypeptide.

A

fusion protein has been constructed for

enzyme immobilization by

fusing a gene for

a P-glucosidase (Abg) and part of the gene for an exoglucanase (CBDcex)^^protein

(Abg-CBDcex) exhibited

glucosidase activity of

bound

to cellulose.

the cellulose-binding properties of

Abg and retained 42%

of

its

the p-glucosidase activity

The sequence Arg-Gly-Asp (ROD)

such as fibronectin, collagen, and laminin mediates

29

Cex and

cell

in extracellular

The

fusion

p-

when

matrix proteins

attachment by interacting with

proteins of the integrin family of cell surface receptors.

CBD/RGD as a linking molecule

reported fusion of
surface^ ^ Protein

between a

research group recently

and a cellulose

cell

A was fused with p-lactamase and adsorbed on IgG-coated Sepharose

matrices with higher specific activities and lower

immobilized p-lactamase^''

.

Km values relative to covalendy

Adsorption of the hybrid protein on the support resulted

increased stability to thermal deactivation.

An

fusion protein which contained calmodulin

(CaM) and

immobilized on a

The same

affinity

in

chromatography system using a
protein

A

(ProtA)^^,

solid support containing phenothiazine through

CaM,

the N-terminus serves as the affinity site for a heat shock protein.

The

was

while Protein

A at

target protein is

released upon addition of ATP and the affinity column can be easily regenerated by
elution of the immobilized fusion with addition of

EGTA

and reloading of fresh ProtA-

CaM.
The above

fusion proteins were immobilized by interactions of the affinity domain

with surfaces through the specific recognition processes drawn from nature,

e.g.,

antibody-antigen, enzyme- substrate or receptor- ligand interactions. Oligopeptides

containing multiple amino acid residues have also been used for protein immobilization

through functional groups on the side chain of the residues. HochuH and coworkers used
N-terminal hexahistidine fusion proteins to immobilize P-galactosidase to the Ni2+nitrilotriacetic acid adsorbent^^.

activity

when bound

from lactose and
Another example

fusion protein retained

64%

of its p-galactosidase

to the adsorbent. Allyl-p-D-galactopyranoside

allyl

is

The

alcohol on a

gram

scale

by the immobilized

provided by a fusion protein

was synthesized

(3-galactosidase.

that contains a polycationic

hexa-

arginine and an N-terminal yeast a-glucosidase^^. This fusion protein can be directly

adsorbed from crude
stability

of

tiie

cell extracts

fusion protein

is

immobilized enzyme was used

good operational

on polyanionic matrices. Upon immobilization,

not affected by pH, urea, or thermal denaturation.
in

column

stability.

30

tiie

The

reactors for production of carbohydrates with

During the

last

decade, our research group has explored biological synthesis
of

polymeric materials, to achieve well-defined molecular architecture including
precisely
controlled sequence, predetermined chain length, monodispersity, and suitable

By

stereochemistry^^.

we have

applying the principles of materials science and structural biology,

synthesized protein-based polymers with lamellar crystal structures, novel liquid

crystal behavior
in the design

and defined functional groups on

surfaces'^^*^'^.

and synthesis of polymeric materials with defined

surface functions,

should be possible to produce hybrid

it

biocatalytic materials to
artificial proteins, in

improve

which

structural properties

artificial

new approach

and

proteins as novel

practical applications of natural proteins.

artificial repetitive

or subunits, are proposed as a

Given these successes

Hybrid

polypeptides are fused with natural proteins

to

combining materials properties with the

biological functions of natural proteins.

The hybrid
2.

1

.

The

natural

function;

Through

artificial

it

is

proteins

domain

fused to an

is

we report

here have the structures illustrated in figure

a natural protein

artificial

domain

the de novo design of artificial

(enzyme or antibody) a

the certain biological

that exhibits desired material properties.

domains

to confer useful

and versatile materials

properties, the hybrid artificial proteins could lead to novel structures and functions and

allow material scientists to harvest biological

membranes.

A

activities in the

forms of

particles, films

few examples include:

(1) self-assembling protein arrays.

defined secondary structures
in a regular pattern

on

(e.g.,

When

repetitive polypeptides self- assemble into well-

p-sheets or a-helices), the natural domain aggregates

the surface of the artificial peptide matrix.

(2) bioreactive surfaces.

When

the artificial polypeptide

functional groups that promote interaction

(e.g.,

is

designed to carry multiple

physical adsorption and chemical

bonding) with surfaces; the natural domain partner retains biological function

enzyme
and

and

for biocatalytic activities, or cell recognition

proliferation, etc.).
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domains

to

promote

cell

(e.g.,

adhesion

(3)

enzyme networks. With

other enzymatic domain

"enzyme

gel".

The

domains forming cross-linked

the artificial

embedded

in the

structures

and the

network, the hybrid protein could produce an

crosslinking density and the mechanical strength of the gel could be

varied with polypeptide functional groups and chain sequence. For example,
by

designing the polypeptide sequence, polymeric gels will undergo conformational changes
with

pH or temperature.

Enzymatic reactions within the

gel could be controlled by

diffusion of the substrate from solution into the gel.
(4) selective

membranes.

When

the artificial

domain self-assembles

membrane

into

structures, the natural partner acts as transport proteins that selectively transport

molecules (ions, small proteins,

As

a model system,

etc.)

we designed

across the artificial membranes.

hybrid

artificial proteins

where the

domain

artificial

serves to bind to surfaces while the natural domain performs a catalytic function.
Versatile protein-surface interaction could be realized by variation of chemical properties

of the

must

artificial

fulfill

groups

domains. In order to achieve the desired properties, the

the following requirements:

at precise positions to

mechanical and physical

(i)

The

domain

useful chemical properties; e.g., functional

promote adhesion of the proteins

stability.

have the following character:

(i)

artificial

to surfaces

and

natural protein domain, on the other hand, should

useful biocatalytic functions;

modification (fusion of artificial domain);

(iii)

(ii)

tolerance towards

ease of assay for activity.

A family of artificial domains was used in this work to gain control over chain length,
chemical and structural properties:

[-(AlaGly)xProGluGly-l-n

.[-(AlaGly)xGluGly-]-n
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1

2

n=16

a:

x=3

b:

x=4 n=16

a:

x=3

n=36

b:

x=4

n=18

c:

x=4

n=28

Such polypeptides can be produced

in E. coli in

adopt random coil or p- sheet structures^!

-

22.

domain

is

x=5

e:

x=6 n=14

n=14

good yield and have been shown

The

glutamic acid residues were expected to provide

d:

to

periodic acidic side chains from the

affinity to basic surfaces.

The

natural

a bacterial phosphotriesterase which catalyzes rapid hydrolysis of

organophosphorus pesticides and nerve agents^^. The phosphotriesterase we used here
contains the modified amino acid sequence reported by Mulbry and coworkers, which

is

characterized by deletion of the 33 N-terminal amino acids of the native enzyme (from
native sequence of pseudomonas diminuta

)

and replacement by the

first

5 lac

Z residues

(Met-Ile-Thr-Asn-Ser-) followed by the enzyme residues (-Gly-Asp-Arg-), in order to

achieve significant improvements in the enzymatic activity in E. coli
the

enzyme can be

degraded

The

activity

of

easily determined, as the pesticide paraoxon can be enzymatically

to release a brightly colored phenolic product with a

nm. The enzyme has shown very good
enzymatic

2"*.

stability

maximal absorption

at

400

and has demonstrated unusually high

activity2^, exhibiting a rate near the diffusion limit with substrate paraoxon2^.

The hybrid

artificial

proteins containing the repetitive polypeptides and

phosphotriesterase were expected to adsorb to basic surfaces through the acidic

domain while

the partner

artificial protein

enzyme

artificial

catalyzes hydrolysis of organophosphates. Such hybrid

designs provide a generic and simple route to immobilization of proteins

without denaturation or loss of enzymatic

activity.

Given the broad substrate range of

phosphotriesterase, the immobilized hybrid proteins are potentially useful for detection

and detoxification of organophosphate pesticides and chemical warfare agents.
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the

2.2 Experimental Section

and Methods

2.2.1 Materials

The

vectors

enzymes

BamH

pET-3b and pET-14b were purchased from Novagen.
I,

EcoR

were obtained from

New

I,

Pst

I

and Nde

as well as

I

T4

ligase

and

Restriction

DNA polymerase

England Biolabs. Ampicillin, Chloramphenicol, paraoxon

(diethyl-/7-nitrophenyl phosphate), (3-cyclohexylamino)-l-propanesulfonic acid (CAPS),

2-(N-cyclohexylamino)ethanesulfonic acid (CHES), (N-2-hydroxylethylpiperazine)-N-2ethanesulfonic acid (HEPES), (2-N-morpholino)-ethanesulfonic acid

(MES) were

purchased from Sigma Chemical Company. All reagents except paraoxon were used as
received. Paraoxon

was

purified

by dissolution

in

dichloromethane following by

extraction with 10

mM CHES buffer, pH 9.0 according to a reported procedure^.

purified paraoxon

was dissolved

4

"C. All the

in

water

in a final

purchased from Qiagen,

Inc.

was obtained from Calbiochem. Ni-NTA

Econo-Pac lODG was obtained from Bio-Rad,

Sephadex A-50 and A-25, and

DEAE

Recombinant

EcoR

I.

The

Inc.

was

DEAE

Division,

W.

R. Grace

& Co.

Inc.

DNA Construction

shown

Raushel of Texas

Amicon

was obtained from Waters

Construction of the recombinant

schematically

resin

QAE Sephadex A-50 were purchased from Pharmacia Inc.

Centriprep 10 ultrafiltration units were from

2.2.2

mM and stored at

DNA manipulations were performed according to standard procedures'^.

Isopropyl-p-thiogalactoside (IPTG)

Protein-Pak

concentration of 0.5

The

in

DNA encoding the hybrid artificial proteins is

Figure 2.2. Plasmid pJK33 (obtained from Professor Frank

A&M University) was digested with restriction enzymes BamH

resulting 1014 bp subcloned
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opd gene encoding

I

and

the phosphotriesterase

was

from an agarose

isolated

digestion of

pUC18

gel.

BamH I and EcoR

with

yield a linear fragment,

The opd gene was

ligated with a 21

bp linker prepared by

pET-3b was digested with

I.

which was purified on a 1% agarose

gel.

The

fragment was combined with the linker modified opd gene (1:5 molar
incubated with

T4

ligase at 15

"C overnight. The

BamH

linearized
ratio)

resulting recombinant

to

I

pET-3b

and

DNA plasmid

(designed pOL-1) was transformed into bacterial strain HBIOI. Colonies were screened
for insertion and insert orientation by digestion with

and 4639 bp fragments) and EcoR

pOL-1 was

digested with

electrophoresis on a

3399 bp

T4

with

1%

agarose

Pst

gel.

I

and the 2334 bp

DNA fragment was isolated by

pET-14b was digested with Nde

DNA fragment was purified as above.
ligase,

BL21(DE3)pLysS. Transformants were

BamH

I

site

encoding the

selected and the

partially digested with

and the

I

BamH

I

coli strain

DNA was verified by Ava
The

I

resulting

and the 5733 bp fragment was

DNA polymerase followed with ligation with T4 ligase to destroy the

on the

3'

artificial

end.

The plasmid was designated pOL-3.

domains was obtained from

recombinant plasmids^^-'^^site

and Pst

The two gene fragments were incubated

digestion (supposed to yield fragments of 486, 1254 and 3993 bp).

incubated with

I

and the ligation product was used for transformation of E.

plasmid (pOL-2) was

1035 bp

(supposed to yield 1524 and 4150 bp fragments).

I

Nde I and

BamH I (supposed to yield

in

BamH I digestion of corresponding

and the appropriated fragment was inserted

of pOL-3. The resulting plasmids

sequences ligated

A family of fragments

frame to the

5'

(pWD-X)

end of the

contain a series

35

coding

DNA encoding the modified

phosphotriesterase of Mulbry and coworkers^"*. Plasmids

transform E.coli strain BL21(DE3)pLysS.

artificial

in the

pWD-X

were used to

BamH

I

2.2.3 Expression of Hybrid Artificial Proteins

Cells containing the recombinant plasmid were
grown in 2

liters

of rich tryptone-

phosphate medium^^ supplemented with 200 mg/ml
Ampicillin, 25 mg/ml

Chloramphenicol and 0.5

mM C0CI2 at 37 'C.

When

expression was initiated by addition of IPTG to the

mM. The growth
around

medium

temperature was then lowered to 30

X.

to a final concentration of 0.4

After 6 hours,

ODgoo reached

1.2-1.5, corresponding to 4-5 g of cells (wet weight) per liter
of culture. Cells

were harvested by centrifugation
resuspended
8.0,

ODm reached 0.8-1.0. protein

300

in

5,000 x g for 10 minutes

at

40 ml of ice-cold sonication buffer (50

at

4 'C. Cell

pellets

were

mM sodium phosphate buffer pH

mM NaCl, 0.1 mM C0CI2 and 0.1% Triton X-100) and stored at -80 °C until

purification. Protein expression

was monitored by SDS-PAGE

after induction.

of one hour

at intervals

-

2.2.4 Protein Purification

After addition of

DNase and RNase

the frozen bacterial cells

be lysed completely

on

—

were thawed

i.e., if

to final concentrations of 10 |ig/ml respectively,

at

the solution

37 °C for 90 minutes.

was not viscous

ice in 5 seconds pulse for 10 minutes.)

The following

A clarified cell lysate was obtained after centrifugation at
added

was

to 8

ml Ni-NTA agarose

stirred gently for

cell

steps

were performed

cm

no significant decrease

until

eluent (approximately 120-150 ml).

The

resin

i.d.).

in

at

4 °C.

The mixture
5,000 x g for

The column was

OD280 was

detected in the

was then washed with 80-100 ml of wash

mM sodium phosphate buffer, 300 mM NaCl, 0.1 mM C0CI2,
36

at

12,000 x g for 30 minutes, and

2 hours. The resin was collected by centrifugation

washed with sonication buffer

appear to

mixtures were sonicated

resin preequilibrated with sonication buffer.

5 minutes and packed into a polypropylene column (1.6

buffer (50

—

(If cells didn't

10%

glycerol,

pH

Further washes were conducted with Tris buffer,

6.0).

MCAC-0

concentrations of imidazole: 50 ml

NaCl,

0.1

mM

7.9 containing low

500 niM

Tris Cl, pll 7.9.

mM C0CI2), 50 ml MCAC-5 buffer (MCAC-0 buffer, 5 mM imidazole), 30 ml

MCAC-20
The

buffer (20

pH

buffer

(MCAC-0

target protein

buffer,

20

was cluted with

mM

4x3

imidazole).

ml MCAC-2(X) buffer (most

target protein in

3rd and 4th fractions). The eluent was immediately subjected to buffer exchange into

HliPliS buffer (50

mM

10%

llliiniS, pll 8.5,

glycerol and 0.1

Rad prepacked licono-Pac lODG column. The

mM C0CI2) using a Bio-

protein solutions were

combined and

loaded on a Sephadex DIvAIl A-5() column (5.0 x 1.6 cm). The column was washed with

40 ml IIEPES

buffer,

60 ml IlF.PnS-.SO

elutcd with 40 ml volumes of
fractions

were concentrated

I

lI^PlvS-

to ca.

1

(IlF.Pl-S buffer containing

100 buffer and

mg/ml by

Proteins were analyzed by electrophoresis on

I

as standard.^"

2.2.5

Fnzyme

Activity

NaCl), and

The

ultrafiltration using a Cenlriprep 10 unit.

12%

wSDS-polyacrylamide

gel.

Quantitative

the Bradford

method with

mM CI IFS buffer

activity

at pi

The

9.0.

1

was measured using paraoxon
reaction

enzyme

Model
that

26(X) spectrophotometer.

hydrolyzes

in

1

50

treated with the hybrid

mM CI IFS buffer

through the absorbance

at

unit of activity

^imol of paraoxon per minute.

was

the substrate of interest

then suspended

1

One

400 nm upon

37

at pi

I

9.0.

as the

was monitored through

absorbance of the product /?-nitrophenolate anion (Xmux 400 nm, c=l7,()(X)
Hitachi

eluted

Measurements

For the soluble proteins, enzymatic
substrate in 150

mM

lI':PnS-3()() buffers.

measurements of protein concentration were made achieved by

BSA

50

is

Fnzyme

')

on a

defined as the amount of

I-or the

i)r()lein (cf.

cm

the

immobilized enzymes,

following section) and

activity

was monitorai

addition of substrate paraoxon.

The

initial

from 0.025

Menten

reaction velcx^ity

to 1.5

mM. The

was measured

kinetic constants

for

paraoxon with concentrations ranging

were determined from the Michaelis-

equation:

V = VmS/(Kn, + S)

where

V is the initial velocity, Vm the maximal

Km the Michaelis constant^^

The

velocity, S the substrate concentration

kinetic constants

were determined by

independent measurements, with twelve paraoxon concentrations

The

rate of

enzymatic hydrolysis of paraoxon

(1

mM)

controlled with the following buffers (100

at least three

each measurement.

was determined

soluble and immobilized forms of the phosphotriesterase at

pH value was

in

pH

and

for both the

values from 4 to

1 1.

The

mM sodium acetate buffer, pH

mM MES, pH 6.0; 100 mM MOPS, pH 7.0; 100 mM HEPES, pH 8.0;
100 mM CHES, pH 9.0; and 100 mM CAPS, pH 10.0 and pH 11.0)

4.0,

pH

5.0;

100

2.2.6 Immobilization Procedure

Sephadex

were

DEAE A-25, Sephadex DEAE A-50, QAE A-50 and Protein-Pak DEAE

tested as substrates for immobilization of the hybrid artificial protein.

were preequilibrated with
protein solution

HEPES

was added

buffer and dried

to the resin

and incubated

washed extensively with HEPES buffer
then resuspended in

HEPES

the difference between the

buffer.

room

at

until

The

no

at

activity

temperature.

The hybrid

was detected

in the

wash, and

was determined from

to the suspension

and the amount

determined from the
present in the wash solutions. Protein adsorption was also
that in the wash.
difference between the activity incubated with the beads and
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resins

4 °C overnight. The resin was

extent of immobilization

amount of enzyme added

The

2.2.7 Activity

An

upon Repeated Use

aliquot of the immobilized hybrid protein

resuspended
(0.2 ^im).

in

1

50

Paraoxon was added

at

filter

of a Spin-X centrifuge u

to start the hydrolysis reaction,

400 nm. The beads

subjected to the

DEAE Sephadex A-50 was

mM CHES buffer, pH 9.0, in the

isolated after 5 seconds by centrifugation.

measured

on

and the supernatant

The absorbance of the

isolated in the upper filter

same procedure through 10

supernatant was

were resuspended and

cycles.

2.3 Results and Discussion

2.3.1 Construction of the Bacterial Expression

Genes encoding

Systems

a series of artificial proteins ligated to the

5'

end of the opd fragment

(which corresponds to residue Asn of the modified phosphotriesterase^"^) were
constructed through recombinant

DNA technology (Figure 2.3). A short linker encoding

9 amino acid residues was derived from the polylinker region of pUC18 and used
the

two fragments of genes

chosen for fusion with the

enzyme: Mulbry and

in frame.

artificial

Kams

The amino terminus of the

domain based on previous

reported that the

enzyme remained

terminal deletion of 33 amino acids and replacement with the

while C-terminal modification resulted

The

in

to fuse

phosphotriesterase

was

kinetic studies of the

highly active with N-

first

5 residues from lacZ,

complete loss of enzymatic activity^.

crystal structure of the phosphotriesterase,

which was solved

recently"*^'

provides insight into the enzyme's tolerance of N-terminal modification. The enzyme

was shown

to

be a homodimer of a/p barrel subunits, with eight parallel p-strands

forming the barrel and flanked on the outer surface by 14 a-helices. The active
each subunit

is

site

of

of
located on the C-terminus of the p-barrel and contains two equivalents
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zinc as a binuclear metal center separated by 3.3 A.
structure, the

two active

sites are located

Upon

formation of the dimer

towards the interface. The two

N termini lie

near the outer surface in an asymmetrical manner and are away from the active
crystal structure of the

enzyme provided support of our design of the hybrid

proteins, in that addition of the artificial
significantly disturb the structure of the

of enzymatic

domain

at the

sites.

The

artificial

N-terminus, which might not

enzyme and might

therefore result in preservation

activity.

A series of genes varying in length from

1641 to 2073 bp (depending on the length of

the artificial domain) were cloned in expression vector pET-14b, a

T7 phage promoter-

driven system originally developed by Studier and colleagues^'^. The recombinant

plasmids were designated

pWD-X, where X

For example, "3PEG16" represents
artificial

domain [(AG)3EG]36.

reflects the

artificial

sequence of the

domain [(AG)3PEG]i6, "3EG36"

Restriction analysis

was conducted

BamH I digestion

were 5730 bp

(all

domain.

depicts

to verify insertion

correct orientation of the insert in the plasmid constructs (Figure 2.3).

fragments resulting from

artificial

The

and

DNA

plasmids) and 504 bp

(pWD-3PEG16), 600 bp (pWD-4PEG16), 936 bp (pWD-3EG36), 612 bp (pWD4EG18), 912 bp (pWD-4EG28), 576 bp (pWD-5EG14) and 660 bp (pWD-6EG14),
respectively.

Ava

I

digestion yielded fragments of

486

bp,

4013 bp

(all

plasmid) and

1735 bp (pWD-3PEG16), 1831 bp (pWD-4PEG16), 2167 bp (pWD-3EG36)

,

1843 bp

(pWD-4EG18), 2143 bp (pWD-4EG28), 1807 bp (pWD-5EG14) and 1891 bp (pWD-

6EG14)

in length respectively.

BL21(DE3) pLysS,

The plasmids were used

to transform E.coli strain

the host for target protein expression.
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2.3.2 Expression of the Hybrid Artificial Proteins

HAP3EG36

2.3.2.1

The

first

hybrid

artificial protein

BL21(DE3) pLysS transformed
protein, designated

with the recombinant plasmid

HAP3EG36,

rate of cell

target protein

T7 promoter recognized by

growth was monitored

strain but without induction, strain

strain

in

but declined in

2.4).

The

pWD-3EG36. The

was expressed under control of a strong

the highly active

T7

RNA polymerase.

BL21(DE3) pLysS pOL-3 (PTE

The

rate of cell

insertion control)

(artificial protein insertion control)

growth prior

to induction

The decrease of growth

rate in

conducted

was normal

and

in

in all cases,

BL21(DE3) pLysS pET-M18

(which produces the polypeptide [(AG)3EG]36) was reported

previously-^^.

behavior of cells that express the hybrid protein very much resembles
artificial

The reduction
protein

artificial

BL21(DE3) pLysS pWD-3EG36 and BL21(DE3) pLysS pET-M18

shortly after induction.

producing the

hybrid

comparison with control experiments using the same

BL21(DE3) pLysS pET-M18^^

tandem (Figure

in E. coli strain

contains the phosphotriesterase fused to the

domain [(AlaGly)3GluGly]36. The
bacteriophage

experiments were carried out

domain

in the

(HAP3EG36)

in

that of the strain

alone.

growth rate was appears

to

depend on the accumulation of a new

BL21(DE3) pLysS pWD-3EG36,

induction continued to grow at the normal

pOL-3, which produces

The growth

rate.

On

as the

same

the other hand,

strain

without

BL21(DE3) pLysS

the recombinant phosphotriesterase (PTE), continued to

grow

/

at

the normal rate after induction, indicating a lack of severe toxicity of the

phosphotriesterase in the
extracts revealed a

much
that

new

BL21(DE3)pLysS

strain.

Gel electrophoresis of the crude

cell

protein of apparent molecular weight ca. 90,0(X) (Figure 2.5),

protein.
higher than the actual molecular weight (64,050) of the hybrid

poly(AG)3EG migrates anomalously slowly under
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similar electrophoretic

It is

known

conditions'^. This behavior has been attributed to the
bias of the sequence of the artificial

domain towards amino
this

acids of relatively low molecular weight, and
to the high acidity of

domain22. Therefore

artificial

polypeptide,

it

is

showed

not too surprising that the hybrid protein, containing
the
the

same anomalous migration. HAP3EG36 was

and showed no degradation during protein synthesis

as determined

stable

by 35s methionine

labeling in a pulse-chase protocol (Figure 2.6).

Whole
added

cell lysates

containing

to protein solution in

150

HAP3EG36 showed enzymatic activity.

mM CHES buffer, pH 9.0.

The

Paraoxon was

reaction mixture

was

subjected to successive wavelength scans as a function of reaction time (Figure 2.7).

The enzymatic

hydrolysis product p-nitrophenolate, as monitored by absorption

nm, increased with time

2.3.2.2 Cell

When

400

as the hydrolysis reaction proceeded.

Growth Conditions

Improvement of Hybrid Protein Production

for

the hybrid artificial protein

medium, SDS-PAGE

at

analysis

HAP3EG36 was expressed at 37 °C in 2xYT

showed

that a large portion of the hybrid protein

— an

inactive, insoluble protein aggregate

formed

inclusion body. Inclusion body formation

is

probably due to the enzyme domain; repetitive polypeptides [(AG)3EG]36 were

expressed

in soluble form-^^,

inclusion bodies

One method
temperature'^.

while the phosphotriesterase was shown largely to form

when expressed

in the

to reduce inclusion

The hybrid

body formation was reduction of cell growth

proteins were expressed at 30 °C in an attempt to reduce

inclusion

body formation. Although

produced

at

lysate.

The

pET vector.

the growth

was slower than

that at

30 °C was more soluble and showed higher enzymatic
specific activity of

than that of samples prepared

HAP3EG36 expressed at 30

at

37 °C (Table
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2.1).

37 °C, the

activity in

HAP

whole

cell

°C was four times greater

The

cell

growth medium also affected the location of proteins expressed

has been reported previously that an enriched growth

reduce inclusion body formation

HAP3EG36 was expressed
phosphate
or

medium up

4xYT, Table

2.2).

to

9 hours

The higher

It

(tryptone-phosphate) could

expression system^^. Indeed

with higher specific activity when grown

compared

after induction, as

activity could also

SDS-PAGE showed

production, as

pET protein

in the

medium

in E. coli.

in tryptone-

to other rich

media (2xYT

be a result of increased target protein

a significantly higher level of expression in tryptone-

phosphate medium compared to 2xYT.

The phosphotriesterase
was reported

that

that

medium were

enzyme expressed

medium

in

with

E.coli^

was

limited to 0.8. Different concentrations of

tested for expression of

HAP3EG36. The

highest enzymatic activity was achieved with 0.5

of Co2+

target protein production did not

in the

native form^.

It

mM Co2+ ion increases

For BL21(DE3) pLysS

cells,

range from 0 to 0.5

mM,

suggests that effect of the cobalt ion

is

seem

Co^^

ion in the growth

specific activity of the hybrid

protein differed significantly with cobalt concentration, as

However,

1

its

mM or 0.75 mM Co2+ was too toxic for efficient cell growth and the

1

optical density

a zinc-containing metalloenzyme in

supplementing of the growth

the specific activity of the

we found

is

shown

in

Table

2.3.

The

mM Co^'*' ion in the growth medium.
to vary strongly with the concentration

as judged

from gel electrophoresis. This

to increase the fraction of active protein

by yielding

higher enzymatic activity of the soluble fraction and/or by reducing inclusion body
formation. This argument

is

supported by previous reports that metal ions

in

metalloproteins can favorably shift the folding/unfolding equilibrium and enhance

thermodynamic

stability

by binding with higher

unfolded or partially folded

states^^*^^.
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affinity to the folded state than to

2.3.2.3 Expression of a Family of Hybrid Artificial
Proteins

As mentioned
proteins

was

in the introduction, the motivation for exploring
hybrid artificial

to enable material scientists to harness biological
function in a controlled and

Toward

systematic manner.

this end, a

to gain control over chemical

family of hybrid

proteins

artificial

and structural properties of the

artificial

proteins prepared contained the phosphotriesterase domain linked
artificial protein

domains with sequences la-b and 2a-e

-[-(AlaGly)xProGluGly-l-n

-[-(AlaGly)xGluGly-]-n

1

2

domain. The

at its

respectively,

was produced

N-terminus to

where

a:

x=3

n=16

b:

x=4

n=16

a:

x=3

n=36

b:

x=4 n=18

c:

x=4 n=28

d:

x=5

e:

x=6 n=14

n=14

All of the target proteins were expressed in Escherichia coli under control of the

phage promoter derived from pET-14b. The growth

were depressed

shown

was analyzed by

production of hybrid

artificial

series of artificial

series, as

artificial repetitive

whole

cell

HAP3EG36, showed

characteristic of the artificial polypeptides.

the

The

protein varied significantly with the sequence and chain

length of the artificial domain.

(AG)xEG

gel electrophoresis of

Figure 2.9. All the proteins, as with

in

anomalous electrophoretic migration

(AG)xPEG

rates of all of the expression strains

shortly after induction, correlated with the artificial protein synthesis

(Figure 2.8). Protein expression
lysates, as

T7

Most obviously, hybrid

proteins containing the

domains were produced more

observed previously for the

artificial

efficiently than those in the

polypeptides alone^^-

polypeptides seemed also to affect proper folding of the hybrid
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The

proteins.

For the (AG)xEG

shown

produce more soluble

to

From

variants, artificial

the above results,

it

domains of longer chain length were

target proteins than the shorter sequences.

appears that

cell

growth and synthesis of the hybrid

proteins parallel the behavior similarly with the artificial domains.

Many

fusions are used to improve heterologous protein expression. Therefore
surprising that the N-terminal artificial

Such observations

the hybrid.

domain determined

N-terminal
it is

not too

the biosynthesis properties of

will be helpful in future hybrid protein designs.

2.3.3 Purification of the Hybrid Artificial Proteins

Hybrid

artificial protein

showed good expression

HAP3PEG

in E. coli,

was chosen

for further studies as the protein

almost comparable with that of the recombinant

phosphotriesterase alone (Figure 2.10). Protein purification was conducted with the
soluble fraction of the lysate. Since there were six consecutive histidine residues attached
to the

N-terminus of the hybrid protein, the target protein was purified by immobilized

metal chelate affinity chromatography.

NTA resin, most E. coli
protein

When

the

whole

cell lysate

proteins passed directly through the

was adsorbed (Figure

column but

the target

2.1 1). After extensive washing, the target protein

eluted with a buffer solution containing 200
histidine for the binding sites

was loaded onto a Ni-

mM imidazole.

was

The imidazole competed with

on Ni and subsequently displaced

the target protein

from the

column.
Imidazole was found to inactivate the hybrid protein rapidly;
hybrid protein were

lost after incubation in

200

95%

of the activity of the

mM imidazole for 24 hours. A size

exclusion column was used to desalt and to separate the hybrid protein from imidazole
the elution buffer.

Sephadex

to

The hybrid

protein

was

further purified by ion

exchange on

in

DEAE-

homogeneity, judging from the amino acid analysis (Table 2.4) and SDS-

PAGE gels (Figure 2.11).

The procedure gave
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2.6

mg of HAP3PEG

1

6 per

liter

of cell

culture (approximately 4-5 g of wet cell weight) with a 37 fold
purification (Table 2.5).

HAP3PEG16 exhibited

specific activity of

3540 units/mg toward hydrolysis of paraoxon,

while the recombinant phosphotriesterase (PTE) showed 5630 units/mg. Therefore
the
hybrid

artificial protein,

exhibited

63%

is

85%

Phosphotriesterase from

artificial

polymeric domain of 13969 Da,

PTE. When normalized with molecular weight,

specific activity of

of the hybrids

activity

containing additional

the

of that of the recombinant PTE.

Pseudomonas diminuta has been

baculovirus expression system with a yield of 2.7

mg

purified

target protein

from the a

from 8 grams of cells

(wet weight)^^. The specific activity of the enzyme was 3,200 units/mg. Subsequently,

Omburo and coworkers

purified a modified phosphotriesterase expressed in E. coli

deletion of the 33 N-terminal

amino acids and replacement with

the

first

5 lac

,

with

Z residues

(Met-Ile-Thr-Asn-Ser-) followed by the Gly34 enzyme residues^, with reported yield of

298

mg

proteins from 160 g of bacterial cells (wet weight).

enzyme was 8020 units/mg using
however,

we

could only use 0.5

BL21(DE3) pLysS
The decreased

cells to

grow

activity of the

lower concentration of Co^"*"
additional

PTE

Co^"*";

efficiently

recombinant
in the

1

and the optical density was limited

PTE

prepared

growth medium.

at the

The

activity of the

proteins represents only about

cell protein is the target protein

work might be

a result of

could also be attributed to the

Da compared

recombinant

from the 37-fold of purification. SDS-PAGE
whole

It

in this

to 0.8.

N-terminus of the reported enzyme; the

enzyme when normalized with molecular weight
The hybrid

For our system,

mM or 0.75 mM Co^"*" was too toxic for

has a molecular mass of 40,247

in E.coli previously.

specific activity of the

mM Co^"*" in the growth medium.

mM

40 amino acid residues

recombinant

1

The

PTE

is

to

82%

34,524

Da

expressed

of that of the reported

of the two proteins.

3% of the
gel,

whole

cell proteins, calculated

however, showed

at least

judging from the band intensity

in

25%

of

Figure 2.10.

inclusion body
Fractionation of the cell lysate and electrophoretic analysis indicated

protein was produced
formation of the expressed proteins. The majority of the target
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in

an insoluble and inactive form with only a small fraction
present

The production of soluble
at

30 'C and extra

protein

in the soluble lysate.

was increased by using lower cell growth temperature

rich tryptone-phosphate

medium. Protein

purification

was

also

conducted on the insoluble fraction of the lysate by immobilized metal
chelate

chromatography using a denaturing protocol from Qiagen. Attempts
inactive hybrid

from the inclusion body by

concentrations of urea in 50

affinity

to refold the purified

dialysis with gradually decreasing

mM HEPES buffers was not successful.

Reactivation of the

insoluble hybrid protein remains to be done in the future for potentially higher yield of
the

hybrid proteins.

2.3.4 Kinetic Characterization of the Hybrid Artificial Proteins

2.3.4.

1

Enzymatic Activity of the Hybrid

Other hybrid

artificial

hydrolysis of paraoxon.

proteins also

Of all

smaller

artificial

showed enzymatic

the proteins constructed,

specific activity (3540 units/mg).
specific activities of

Artificial Proteins

The

purified

660 and 360 units/mg

activity with respect to catalytic

HAP3PEG16 gave

HAP4EG18

and

the highest

HAP4EG28

yielded

respectively, suggesting that hybrids with

domain was more enzymatically

active.

2.3.4.2 Initial Velocity of the Enzymatic Reaction

Purified

HAP3PEG16 was

The progress of the
paraoxon was

subjected to kinetic study using paraoxon as substrate.

catalytic reaction

initiated

is

shown

in

Figure 2.12. The hydrolysis of

upon addition of the hybrid

the increase in absorbance at

400

nm

arising

protein and monitored by measuring

from the hydrolysis product p-

from which
nitrophenolate. Initially the product formation increased linearly with time,
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the initial slope can be estimated to
yield an

initial velocity^^.

As the reaction proceeded,

the fall in substrate concentration or/and
product inhibition resulted in a velocity
decrease

with time. All of the kinetic studies
velocity,

which

is

2.3.4.3 Effect of

the velocity

v

The

=

work were based on measurement of the

initial

hereinafter referred to as "the reaction velocity".

Hybrid Protein Concentration

The enzymatic

HAP3PEG16

in this

hydrolysis of paraoxon

was measured

at different

concentrations of

using a large excess of substrate (Figure 2.13). Under such
conditions,

was

therefore proportional to the protein concentration^^

k[E]

(2.1)

reaction velocity, determined from the

slope of the absorbance vs. time curve,

initial

indeed showed a linear correlation with the hybrid

artificial protein

concentration (Figure

2.14)

2.3.4.4 Effect of Substrate Concentration

The
fixed

reaction velocity

was measured

amount of the hybrid

protein.

at different

As shown

in

concentrations of paraoxon with a

Figure 2.15, the reaction velocity

increases initially with substrate concentration and gradually levels off.

be

fit

The curves can

with the Michaelis-Menten kinetic equation and show very good agreement. This

result indicates that the hybrid follows the

reported for the phosphotriesterase^.

Menten

in

same Michaelis-Menten mechanism

The mechanism,

first

developed by Michaelis and

1913, has been the foundation the greater part of enzyme kinetics^^
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as that

According

to the theory, the

subsequently breaks

forms a complex with

first

giving the free

enzyme and

(2 2)

a steady state assumption where the concentration of enzyme-substrate
complex

= Vm[SJ

where v

/

(Km +

-

(2.3)

the initial velocity,

is

Vm

as:

[SJ)

Km the Michaelis constant.

V

substrate and this

the products of the reaction.

remains constant, the reaction velocity can be obtained

V

its

^ E+ P

E+ S = ES

Under

down

enzyme

Vm the maximal velocity, S

At

the substrate concentration and

saturating substrate concentrations,

when

= k[E]

to the

2.1, in

agreement with the

Michaelis-Menten equation,

results

if 1/v is

line should be obtained, corresponding to the reciprocal

shown

in

Figure 2.14.

plotted against 1/S, a straight

form of the equation

i = J_ + ]^.±
V

Such

Vo,

plot,

v.

Km,

(2.4)

which would give equation
According

[S] »

(2.5)

[S]

(Lineweaver-Burk

plot)^^ indeed

gave linear correlation for the hybrid protein

PTE

(Figure 2.16).

The

and for the recombinant
plots (Table 2.6).

the value for

The

kinetic constants

catalytic rate constant (kcai) of the hybrid

PTE. The

Km value of the

hybrid protein

is

were obtained from the

was shown

to be

66%

lower than that of the

recombinant PTE, suggesting a more favored enzyme-substrate complex formation for
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of

the hybrid than for the

enzyme

alone.

As

a result, kcat/Km for the hybrid

is

81%

of that

of the recombinant enzyme. Since the products of the hydrolysis reaction are
both
anionic in the reaction buffer at
artificial

site

pH 9.0,

it

is

possible that expulsion between the anionic

domain and products encouraged leaving of the products from

and therefore

shift the

the

enzyme

active

equilibrium of the enzyme-substrate complex formation.

The decrease of enzymatic

activity in the hybrid protein

disturbance of protein folding of the

enzyme domain by

sequence of HAP3PEG16 was subjected

to

might be due to

partial

the artificial partner.

The

computer simulation. The obtained

secondary structure of the enzyme domain was compared with crystal structure of the

enzyme determined by X-ray

The computer prediction of the

diffraction analysis-''^.

hybrid showed preservation of 5 out of 8 P strands, mostly

in the latter half

of the

sequence. Most of the a-helical structure of the enzyme domain was disturbed, with only

6 out of the 14 helices predicted,
the secondary structure of the
circular dichroism

all at

the

C teiininus of the enzyme.

two domains of

and two dimensional

the hybrid could be

Detailed study of

done

kcat,

of 2500

s"^

hybrid was sufficiently active for catalytic hydrolysis of paraoxon. The
is

by

NMR.

Nevertheless the absolute value of catalytic constant,

hybrid protein

in the future

similar to that of the recombinant

ionizable group important for activity of the

PTE

enzyme was

indicated the

pH

profile of the

(Figure 2.17), suggesting that the
not significantly affected by the

artificial fusion.

2.3.5 Immobilization of Hybrid Artificial Proteins

Given
artificial

the multiple carboxylate functional groups

domain, the hybrid proteins were expected

surfaces through electrostatic interactions.
that the artificial

domain contained

1 1

from the glutamate residues of the

to

be selectively adsorbed to cationic

Computer simulation of HAP3PEG16 showe

glutamic acid residues that are entirely accessible

50

tc

solvents (with reliability >70%); around

domain were on

70%

of glutamic acid residues from the

artificial

the outer surface and gave the anionic character of
the hybrid protein

Computer simulations

showed

also

that the artificial

domain

is in

random

.

coil structure,

with the probability of coil more than 80%.

DEAE-Sephadex A-50, an

Affinity toward

both

HAP3PEG16 and

anionic exchange resin, was tested for

the recombinant phosphotriesterase (PTE). Purified proteins

were loaded onto DEAE-Sephadex column and
buffer,

pH

protein

8.5 containing different concentrations of

was eluted with 50

sodium

mM HEPES

chloride. Elution of the

hybrid and the enzyme was monitored by the enzymatic activity of the eluent. Elution of

HAP3PEG required
without added

salt

1(X)

mM NaCl while PTE was found in the

little

elution fraction,

(Figure 2.18). These results clearly demonstrate that the hybrid bound

to the cationic surfaces through the anionic artificial domain; the

showed

first

binding.

The

enzyme domain

itself

isoelectric point (PI) of the hybrid is calculated to be 6.02,

while that of the recombinant phosphotriesterase

is 8.7.

At

pH

immobilization was done), the anionic form of hybrid protein
hand, the recombinant enzyme

is

essentially neutral.

The

is

8.5 (where the

dominant; on the other

difference of PI values of the

hybrid and the enzyme explains the selective binding of the hybrid to cationic surfaces.

Other hybrid

The

artificial

ionic interaction

varied

proteins also

was probed using whole

number of anionic groups on

showed

selective adsorption to cationic surfaces.

cell lysates

the artificial domain.

containing hybrid proteins with

The HAP3PEG16

different affinity with the resin than the pure protein, with

200

mM NaCl (Figure 2.19).

that

of HAP3PEG16, although

artificial

as

showed

HAP3EG36 exhibited
it

binding to

and

HAP4EG28,

DEAE Sephadex.

at

contained 20 additional glutamic acid residues on the

also didn't

seem

However, with

number of hydrophobic amino

most protein eluted

ion exchange behavior similar to

domain. Proteins with same repeating sequence but

HAP4EG18

cell lysate

the

to

show

different chain length, such

significant differences in

same number of charges but

different

of
acid residues on the artificial domain, as in the case
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HAP3PEG16 and HAP4PEG16,
I1AP4PEG 16 showed

behavior.

respectively,

which

clear although

it

is

is

interesting

there

is

a significant difference in ion exchange

a bimodal elution

100 niM and 300

at

and puzzling. The reason for the bimodal elution

suspected there

a nionomcr-dinier equilibrium of

is

A variety of cationic resins functionalizctl

bind to silica beads and to

silica

HAP4PEG16.

Both

2.7).

The hybrid

amino functional groups did not adsorb

was

protein

adsorbed on positively charged hydrophilic surfaces through ionic

the hybrids.

immobilized on amino surfaces when polyglutamic acid

(MW 50(K)) and

HAP on

hydrolysis of paraoxon.

10%

The

DEAE-Sephadcx

resin exhibited

relative activity of the

enzyme, suggesting a

hybrid protein was highly active

relative activity of

in

polystyrene

catalytic activity for

HAP3PEG16 was

less

large diffusion effect"*". Considering that the

in solution, a

decreased diffusion rate of substrate upon

immobilized

With Protein-Pak

DMAE,

activity.

HAP3PEG 16 was increased

decrease in resin particle sizes ranging from 0.8 |im
2.8.

low

immobilized

immobilization will significantly lower the apparent enzymatic

Table

were not

of that of the soluble proteins. Kinetic analysis gave a K,n value of KXM) |iM

for the immobilized

The

direct

to the incubation buffer.

The immobilized

than

selectively

Another

that hybrids

was added

and

interaction; hydrophilic

evidence of ionic interaction arises from the observation

sulfonate

PTE

coupled with aminopropyl

trimethoxysilane under a variety of pli conditions.

surfaces without

not

is

with primary, tertiary and quaternary amino

groups were studied for hybrid protein immobilization (Table

HAP3PEG16

mM NaCl

to 2(X)

|im

in

a polyacrylate based anionic

substantially with

diameter, as

exchange

diameter, the relative activity (kcai) of the immobilized hybrid protein was

compiu-ed to the soluble fonii (Table

2.6).

The small

shown

in

resin 15 ^im

72%

resin particles provided

more

hindrance for the
surface area in contact with solution and therefore generated less steric
diffusion of the substrate from bulk solution to the solid support.
effect

was reduced when

the protein

was immobilized on
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The

internal diffusion

the outer surface of the resin

)

instead of within the pores.

The

relative activity of the

immobilized

HAP3PEG 16 on

Protein-Pak

DEAE was increased with more resin used for immobilization (Table 2.9)

and reached

maximum

at

mg of beads, corresponding to approximately

3 units per

monolayer coverage of the hybrid on
hybrid

is

the outer surface of the resins.

80 A, estimated from addition of diameter of

and diameter of the

artificial

domain (30 A, end

to

the

enzyme

The diameter of the

subunit (50 A^^-

end distance as ramdom

'*^)

coil

structure"*^

A kinetic study of HAP3PEG16 immobilized on Protein-Pak DEAE microspheres
was conducted. The Lineweaver-Burk

plot indicated that the immobilized hybrid also

followed Michaelis-Menten kinetics. The value of kcat for the immobilized hybrid was

shown

to

be 1800

(Table 2.6). The

s

^ yielding

72%

relative activity

Km of the immobilized protein is

comparing with the soluble form

5 times greater than that of the soluble

form, attributed to the diffusion hindrance of substrate to the heterogeneous active center

upon protein immobilization (compared

to the diffusion of substrate to the active site of

the soluble enzyme). Another factor for the increase in

Km is the affinity of product p-

nitrophenolate to the cationic matrix.

2.3.6 Application of Immobilized

HAP in

Application of the immobilized hybrid

an

Enzyme Reactor for Pesticide

artificial protein

was demonstrated

reactor for rapid hydrolysis of organophosphate pesticides.

recombinant

PTE were

loaded on

Detoxification

HAP3PEG16

in a

column

and

DEAE Sephadex A-50 columns, and after extensive

wash, paraoxon was loaded on the column. The yellow hydrolysis product /?nitrophenolate appeared rapidly on the column containing immobilized hybrid
proteins; the

the

enzyme

column

that contained

recombinant

couldn't bind to the resin and

enzyme column showed good

stability
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PTE showed

was washed

off the

with repeated uses, as

artificial

no hydrolysis reaction since

column (Figure

90%

2.20).

The

of activity remained

after 10 cycles of use (Figure 2.21). Furthermore,
as demonstrated previously, the

protein can be eluted at high ionic strength; providing easy
and economical regeneration

of the column reactor when the immobilized protein loses
applications of the immobilized hybrid protein include
pesticide detection, as Protein-Pak

DEAE

is

an

activity.

Other potential

HPLC column devices for

HPLC resin.

Given

the broad substrate

range of the phosphotriesterase, the immobilized hybrid proteins are potentially
useful for
detection and detoxification of organophosphate pesticides and chemical warfare
agents.

2.4 Conclusions

We have developed novel hybrid artificial proteins in

which

artificial repetitive

polypeptides were fused with a natural protein or domain. Such hybrids will allow
materials scientists to harness biological functions in the form of biocatalytic surfaces,
reactive

membranes, protein arrays and enzyme networks. As

produced hybrid

artificial

proteins as "sticky

to bind to surfaces while the natural

hybrid

artificial proteins

enzymes" where

domain performs

containing the

artificial

a

model system, we

the artificial

catalytic activities.

domain served

A family of

sequence motif [(AlaGly)nXGly]ni (X =

ProGlu or Glu) and the phosphotriesterase was synthesized through recombinant
technology.

DNA

We explored the behavior of hybrid artificial proteins with artificial domains

with systematically varied sequence and chain length. The hybrid proteins exhibited
excellent catalytic activity for rapid hydrolysis of paraoxon. For one of the hybrid

variants

(HAP3PEG16),

the kcat value

was 2500 s'K 66% of the value of the

recombinant phosphotriesterase (PTE). The
than that of PTE, and results in kcai/Km

81%

Km value of the hybrid protein was lower
of the value of PTE. The hybrid

artificial

proteins were selectively adsorbed on cationic surfaces through electrostatic interaction

with the anionic
active, with

artificial

72%

domains. The immobilized hybrid protein remained highly

of kcat of the soluble form. The immobilized hybrid was used
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in a

column

reactor for detoxification of the organophosphate pesticide paraoxon. Hybrid

artificial proteins,

combining materials properties of artificial polypeptides with the

biological functions of natural proteins, provide a simple route to self-assembled
biocatalytic surfaces.
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& Hall,

Table 2.1 Effect of growth temperature on enzymatic

Time

0.5

activity of

HAP3EG36^

after induction (hours)

2

1

3

4

Specific Activity (Units/mg protein)

37

30

T
T

^Activity

0.06

0.50

0.52

0.38

0.45

014

027

L34

LOT

1,92

was measured with whole

cell lysate; cells

medium.

59

were grown

in

2xYT

Table 2.2 Effect of growth medium on

HAP3EG36^

activity of

Time

after Induction (hours)

3

6

Media

9

Specific Activity (Units/mg protein)

2xYT»>

1.2

1.27

0.17

4 xYTc

1.33

1.62

0.38

Tryptone-phosphate^

1.95

3.21

0.80

^Activity

was measured with whole

cell lysate; cells

*'1.6% bacto-tryptone, 1.0% yeast extract, 0.5%

c3.2% bacto-tryptone, 2.0% yeast

d2%

bacto-tryptone,

extract,

were grown

at

30 'C

NaCl

1.0% NaCl

0.2% Na2HP04, 0.1% KH2PO4, 0.8% NaCl, 1.5%

and 0.2% glucose.

60

after induction.

yeast extract,

Table 2.3 Dependence of activity of HAP3EG36 on concentration of cobalt ion

in the

growth medium^

Co

2+

Time

Concpntratinn

60

(mM)

after induction (minutes)

120

180

240

(units/mg of protein)xlO(X)

0

5.8

5.8

6.0

8.0

0.25

8.4

36.0

68.0

140

0.5

11.0

9.6

550

600

1.0

10.0

7.3

19.0

6.2

a2xYT medium,

at

30 'C.
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Table 2.4 Purification of hybrid
Fraction

Total protein

artificial protein

Total activity

HAP3PEG16
Specific

Yield

Purification

activity
UflllS

X

I

fnld
JOIU

Lr

Cell lysate*

612

5.85

96

100

1

Ni-NTA

23.6

3.95

1670

67.5

17.5

DEAE A-50

5.2

1.84

3540

32

37

^ Isolated

from 2

liter

cell weight; the cells

of OD600
after induction

of culture grown to a

were grown

at

30

62

cell density

= 1.280 and

4.5 g/L wet

Table 2.5

Amino

*

Amino

acid composition of the

acid

HAP3PEG163

Predicted''

Anal vsis*^

Ala

16.4

16.0

Gly
Glx(Glu+Gln)
Asx(Asp+Asn)
Phe

18.5

19.3

8.4

8.8

5.3

5.5

2.9

3.1

His

2.8

2.7

De
Lys
Leu
Met

4.8

4.1

1.7

2.0

6.5

6.0

2.2

2.1

Pro

6.6

7.0

Arg

6.1

6.3

Ser

6.5

6.8

Cys
Thr

0.4

0.04

4.6

4.7

Val

4.4

4.0

Tyr
Trp

1.3

1.4

0.7

ND

Measurements based on mol%

^Deduced from

the

DNA sequence encoding the protein

^Values were obtained by calculations based on molecular weight

of 53,884, derived from amino acid sequence

^ND: not determined
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Table 2.6 Kinetic constants

Proteins

kcat(sec-i)

Km

(|iM)

kcat/Km
(10^ M-'

HAP3PEG16

25001280

120

±40

2.1

PTE

3880 ±220

150

±30

2.6

±200

870

±50

0.21

Immobilized HAP**

Measurements based on

1800

HAP3PEG16

64

immobilized on Protein-pak

s-i)

DEAE resins

Table 2.7 Immobilization of proteins on different surfaces^

pH

6.8

beads'^

PTE

HAP3PEG16

Si-OH

+

-1-

Si-NH2

+

+

Si-OH

+

+

Si-NH2

+

+

Si-OH

+

+

Si-NH2

+

Si-OH

—

—

Si-NH2

—

—

Streamline

+

+

8.5

11

NaOH

8.5

DEAE

8.5

Sephadex

—

—

8.5

polyacrylamide

—

—

8.5

Sephadex-

—

+

DEAE
8.5

8.5

Sephadex-QAE

+

Protein-Pak

+

DEAE

aProteins were incubated with beads at indicated pH for 2 hours at 4 °C. The beads were
HEPES buffer, pH 8.5, before measurement of activity
washed extensively with 50
paraoxon. Activity observed on
in the wash and of the beads for hydrolysis of 0.5
"-»-"
and no activity on beads (up to 60 seconds) is represented as
beads is represented as

mM

ft

mM

ti
•

bSi-OH

are silica microspheres of 0.8 |im in diameter.

Si-NH3

are

Si-OH coupled with

aminopropyl trimethoxysilane. Streamline DEAE is agarose beads functionalized with
DEAE (diethylaminoethyl) and contains small silica core.
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Table 2.8 Relative activity of immobilized

Beads

HAP3PEG16

DEAE

QAE

Streamline

DEAE

Silica-

A-50

A-50

DEAE

A-25

amino

Silica

Protein-

Pak

DEAE
Diameter

(^m)

200-300

200-300

^.0

6.5

100-200

0.8

0.8

15

9.3

59.8

56.4

72.0

Relative
Activity^

9.1

(%)
^Based on

ratio

of kcat value of immobilized and soluble proteins.
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Table 2.9 Immohili/ation of lAP on protcin-Pak 1)1{AI{^
1

Amount
resin

of

i

2

4

6

8

10

37

42

53

4^

^2

39

(mg)

Relative
Activity"^

(%)

»The amount of protein used
eonducted

at

50

mM

is

25 units for each experiments. Immobili/.ation

lIAPIiS buffer, pli

8.5.

is

Details see lixperimenlal Section.

^^Based on ratio of specific activity of immobilized protein and soluble protein for

hydrolysis of paraoxon.
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Natural

Domain

mm m
Artificial

Figure 2.1

Domain

A schematic illustration of the design of hybrid artificial proteins
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N B
1.

2.

Linker
T4 Ligase

Cut

Linker:

B

T4 Ligase

5'

BamHI
gatccccgggtaccgagctcg
gggcccatggctcgagcttaa

EcoRI

Restriction

N

Enzvmes:

Cut N, P

E - EcoR I, B - BamH I

N - Nde

I,

P

-

Pst

Cut N, P

1

I

T4 Ligase

L

Partial digestion with

2.

DNA polymerase

3.

T4 ligase

Figure 2.2 Schematic diagram of

BamHI

DNA construction for the expression of the hybrid

artificial proteins (a)

Continued next page
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Figure 2.3, continued

pOL-3

pET-X

5730 bp

B
(B)

B
B

CutB
CutB

B
I

I

I

T4 ligase

Enzvme

B -BamHI
1.

2.

Hybrid

Transform into

BL21(DE3)pLysS
IPTG

Artificial Protein

(b)
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I

I

l~TT

504 bp
lb: 600 bp
2a: 936 bp
2b: 612 bp
2c: 912 bp
2d: 576 bp
2e: 660 bp
la:

Restriction

I

(HAP)

(1)

(2)

(3)

(4)

(5)

(6)

(7)

5686 b
4822 b
3675 b
2323 b
1929 b
1371 b
1264 b

702 b

Figure 2,3 Restriction analysis of recombinant plasmids containing genes encoding
hybrid

Lanes

artificial proteins, a)

2-4:

BamH

I

Lane

1:

Lambda DNA-BstE

digestion of plasmids

pWD-6EG 14 respectively;

Lanes 5-7 Ava

3PEG16, pWD-5PEG14, pWD-6EG14

II

digestion.

pWD-3PEG16, pWD-5PEG14,
I

digestion of plasmids

pWD-

respectively.

Continued next page
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Figure 2.3, continued

(1)

b)

Lanes

plasmids

1:

(2) (3) (4)

Lambda DNA-BstE

II

(5)

(6) (7)

digestion.

(8)

Lanes 2-5:

BamH

I

digestion

pWD-3EG36, pWD-4PEG16, pWD-4EG18, and pWD-4EG28

respectively;

Lanes 6-8 Ava

4EG18, and pWD-4EG28

I

digestion of plasmids

respectively.
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pWD-4PEG16, pWD-

1.2

0.6-1

0

1

1

1

1

1

1

1

0.5

1

1.5

2

2.5

3

3.5

4

Time After Induction (Hours)

Figure 2.4 Cell growth curve for expression of

HAP3EG36.

Cell growth

a change in optical density of the culture as a function of time.
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is

measured as

Negative Control

Positive Control

[(AG)3EGl36

0

60

0

PTE

60 120

0

120

HAP3EG36
0

30

Figure 2.5 Electrophoretic analysis of expression of hybrid
at

60

90 120 150 180

artificial

protein

various time point (minus) after the addition of IPTG. The

molecular weight markers (from top
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HAP3EG36

first

to bottom, 200, 97, 66, 43,

lane

is

29 kDa)

PTE
Time

HAP3EG36

after

induction (min)

0

30

200 kDa-^
97

kDa—

66

kD

—

43 kDa

29

kD

Figure 2.6. Pulse-chase experiments of PTE and

by

methionine labeling
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HAP3EG36

in E.coli

Wavelength (nm)

Figure 2.7 Wavelength scan of hydrolysis reaction of paraoxon by whole
containing

HAP3EG36
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cell lysate

0

0.5

Time

Figure 2.8 Cell growth curve for

change

in the optical

1.5

1

2

2.5

3

4

3.5

after induclion (hours)

tiirget

protein expression. Cell growth

is

measured as a

density of the culture as a function of time.
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SDS-PAGE analysis of expression
E. coli strain

of a family of hybrid

BL21(DE3)pLysS. a)Lane

1,

molecular weight markers (from

top to bottom, 200, 97.4, 66, 45 kDa); lanes 2
at 0, 1, 2, 3

artificial proteins in

-

6:

HAP3PEG16 cell

and 4 hours after IPTG induction; lanes 7-11:

cell lysates at 0, 1, 2, 3

and 4 hours

after

IPTG

lysates

HAP4PEG16

induction, respectively.

Continued next page
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Figure 2.9, continued

1

b).

4

3

_2_

Lane

1,

5

7

8

9

10

11

molecular weight markers (from top to bottom, 200, 97.4, 66, 45

kDa); lanes 2

-

6:

induction; lanes

IPTG

6

HAP4EG18

cell lysates at 0, 1, 2, 3

7-11: HAP4EG28

and 4 hours

cell lysates at 0, 1, 2, 3

after

and 4 hours

IPTG
after

induction.

Continued next page
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Figure 2.9, continued

123456
*

^

c)

Lane

^

1,

10

11

molecular weight markers (from top to bottom, 200, 97.4, 66, 45

kDa); lanes 2

-

6:

induction; lanes

IPTG

789

^

HAP5EG16 cell

2-11:

ly sates at 0, 1, 2, 3

HAP5EG14 cell

induction
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and 4 hours

ly sates at 0, 1, 2, 3

after

and 4 hours

IPTG
after

,

123 456

7

8

9

10

11

97KDa-

^rn^m m #"'Target
protein

45

KDa—

.

31 KDa-

Figure 2.10

SDS-PAGE

analysis of expression of

BL21(DE3)pLysS. Lane

1,

97.4, 45 and 3 1 kDa); lanes
2,

3 and 4 hours after

IPTG
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HAP3PEG

in E. coli strain

molecular weight markers (from top

2-11: PTE and

HAP3PEG cell

induction, respectively.

to

bottom,

lysates at 0,

1

1

Figure 2.1

1

SDS-PAGE

HAP3PEG16. Lane
97.4,

2

1,

3

4

of purification of

5

tiie

hybrid

6

artificial protein

molecular weight markers (from top

45 and 31 kDa); Lane

to

bottom,

2: cell supernatant; lane 3: fraction that

went through Ni-NTA column upon loading of cell supernatant; lane 4:
eluted fraction from Ni-NTA column with sonication buffer containing
200
imidazole; lane 5-6 eluted fraction from DEAL Sephadex A-50
HEPES buffer, pH 8.5 containing 200 mM NaCl
column with 50

mM

mM
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Figure 2.12 Reaction progress of catalytic hydrolysis of paraoxon by

HAP3PEG16,

under conditions: [HAP] =0.15|ig/ml, [Paraoxon] =0.15

CHES

buffer,

pH

9.0 at

room

83

temperature.

mM,

150

mM

0.70

^ig

0.56

^ig

0.42 ng

6
t - t

mix

8

(seconds)

gure 2.13 Effect of hybrid protein concentration on hydrolysis of paraoxon (0.5
in

150

mM CHES buffer, pH 9.0.

84

mM),

Amount

of

HAP3PEG16

Figure 2.14 Effect of hybrid protein concentration on
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initial

(|ig)

reaction velocity

1

1

1

0.04

o
B
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>
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a
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1

1

1
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1

1

1
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1

1
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1

1

1

1
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1

1

1
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600

1

1

1

1

1

1

1

700

1

800

[Paraoxon] ()iM)

ure 2.15 Effect of substrate concentration on

HAP3PEG16

(0.2 ng/ml) in 150

86

initial

reaction velocity, using

mM CHES buffer, pH 9.0

/

Figure 2.16 Lineweaver-Burk plot of the hybrid
the recombinant

PTE

(o).

87

artificial

protein

HAP3PEG16

(•)

and

Figure 2.17

activities

of

HAP3PEG

paraoxon and 2 |ig/ml of proteins,

in

150

pH

profiles of

enzymatic
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and PTE, with 0.5

mM

mM CHES buffer, pH 9.0.

100

HEPES, pH

8.5

DEAE Sephadex A-50
80-

>
C

60-

HAP3PEG16
PTE

0
>

40-

20-

0

r-T

0

0.05

I

I

I

0.1

I

0.2

0.3

0.4

0.5

LNaCl] (M)

Figure 2.18 Ion exchange chromatography of purified

Sephadex A-50. The enzymatic

CHES

buffer,

pH

activity of eluent is

9.0 and with 0.5
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HAP3PEG

and

PTE

measured

mM of paraoxon.

using

in

150

DEAE-

mM

100

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

NaCl (M)

Figure 2.19 Ion exchange chromatography of cell
using

DEAE-Sephadex A-50.
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ly sates

of hybrid

artificial proteins

Figure 2.20 Application of immobilized hybrid
hydrolysis of paraoxon.

column contains

artificial proteins in

Column on

the

DEAE Sephadex A-50.
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left:

column

HAP3PEG16,

reactors for

right:

PTE, both

100

I

80

-

60

-

40

-

20

-

0
8

10

Cycles of use

Figure 2.21 Stability of immobilized

measured using

1.0

HAP3PEG

under repeated use. Activity

is

mM paraoxon in 150 mM CHES buffer, pH 9.0.
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CHAPTERS

IMMOBILIZATION OF RECOMBINANT PHOSPHOTRIESTERASE FOR RAPID

HYDROLYSIS OF ORGANOPHOSPHATE PESTICIDES

3.1 Introduction

Immobilized enzymes offer many advantages over soluble enzyme preparations
including reusability, compatibility with continuous catalytic processes and ease of
separation from the product in batch operations^

Many

immobilized enzymes have been

reported to gain stability with respect to denaturation upon heating or prolonged storage.
In addition, immobilized

the

enzymes have been proposed

mechanisms of enzymatic

to serve as

reactions in vivo^. Since the

first

model systems

to study

commercialized

immobilized enzyme was introduced nearly 30 years ago^, numerous examples have been
developed for heterogeneous biocatalysis
immobilized enzymes have been applied
in medicine, food quality control

in industrial processes'*.

in biosensors

More

recently,

and have found increasingly usage

and environment monitoring^.

Organophosphorus compounds are widely used

as pesticides for agricultural

and

domestic applications, functioning as inhibitors of acetylcholinesterase^. However, these

compounds

raise environmental concerns

owning

Organophosphate pesticides are highly toxic by

to their acute toxicity

all

.

routes of exposure including

ingestion, dermal absorption and inhalation^. Repeated and prolonged exposure to

organophosphates

may

result in severe

damage

to the central

nervous system.

Contamination by residual organophosphate pesticides has been found widely

ground water and vegetation^.

93

in soil,

Analysis of organophosphate pesticides

is

most frequently performed by gas

chromatography (GC) with element-selective or mass- selective

Although

detectors^.

residues can be detected with these methods to parts per billion (ppb), the
required

instrumentation

is

expensive and the analysis

is

time-consuming. In contrast, enzyme

based biosensors, with the advantages of specificity,

sensitivity, easy signal detection

small size, would appear to offer special promise^^.

An enzymatic method

and

based on

inhibition of acetylcholinesterase activity has been studied intensively for

organophosphate detection^ ^ However, the measurement involves

at least a

two-step

process (inhibition and activity assay), and reactivation of the enzyme.

The

phosphotriesterase originally found in

Flavobacterium
This enzyme
pesticides.

sp.,

Pseudomonas diminuta

MG and

provides a good candidate for use in the construction of biosensors.

capable of direct, specific and fast determination of organophosphate

is

The phosphotriesterase hydrolyzes

a

wide variety of organophosphates

including

some of the most commonly used organophosphate

agents^^.

The

catalytic hydrolysis reaction has

who have demonstrated

coworkers^

pesticides

and deadly nerve

been studied extensively by Raushel and

that substrates such as

paraoxon (diethyl-p-

nitrophenyl phosphate), can be hydrolyzed at rates near the diffusion limit'^. The crystal
structure of the

enzyme suggests

39 kDa subunits^^. The active
separated by 3.3

and expressed

that the phosphotriesterase consists of a

site

homodimer of

of each enzyme subunit contains 2 equivalents of zinc

A as a binuclear metal center. The phosphotriesterase has been cloned

in E.coli

with deletion of the 33 N-terminal amino acids^^-

Hydrolysis

of paraoxon produces a brightly colored phenolic product with an extinction coefficient of
17,000 M-^cm-i

at

400 nm, which can be detected

quantitatively

by UV-vis absorption

spectroscopy.

Immobilization of the phosphotriesterase through physical adsorption on
has been reported^l The resulting immobilized enzyme exhibited
the soluble

enzyme

in

degrading paraoxon. However,

94

this

40%

trityl

agarose

of the activity of

immobilization method was

complicated by the fact
trityl

that

paraoxon (and other substrates) showed some

affinity to the

agarose matrix. In order to suppress adsorption of paraoxon,
addition of

methanol was required. In an

10%

earlier report bacterial cell lysates containing

phosphotriesterase were covalently bound to controlled porous glass (CPG)
and

(CPS)^^;

3-41% of relative

loading.

The maximal

per gram of porous

activity

were

relative activity

silica.

retained,

silica

depending on the level of protein

was achieved with only 7

units of

Since the study was conducted with crude

enzyme bound

cell extracts,

quantitative kinetic measurements were not reported. Both of these systems have been

proposed as continuous flow devices for detoxification of organophosphates.
This chapter will present the synthesis, purification and immobilization of a

recombinant phosphotriesterase (PTE) which catalyzes rapid hydrolysis of
organophosphate pesticides such as paraoxon. The highly active recombinant enzyme

was

easily purified, and a simple

method

for immobilization

as the solid support for immobilization because of

good thermal

stability,

addition, silica

and resistance

immobilized on

and

is

silica

has been

low

to organic solvents

would not be expected

the complications encountered with

its

to

trityl

shown

was

used.

cost, high

We chose silica

mechanical strength,

and microbial

attack^^. In

bind paraoxon and should therefore be free of
agarose.

The recombinant

phosphotriesterase

to be highly active towards hydrolysis of paraoxon

expected to be potentially useful for rapid detoxification and detection of

organophosphorus pesticides.

3.2 Experimental Section

3.2.1 Materials

Paraoxon (diethyl-p-nitrophenyl phosphate), [3-cyclohexylamino]-l-propanesulfonic
[N-2acid (CAPS), 2-[N-cycIohexylamino]ethanesulfonic acid (CHES),

95

hydroxyethylpiperazinel-N-2-ethanesulfonic acid
ethanesulfonic acid

(HEPES) and (2-N-morpholino)-

(MES) were purchased from Sigma Chemical Company.

paraoxon were used as received. Paraoxon was purified according
procedure^l and was dissolved in

The

vectors

BamH
resin

I,

Pst

I

and Nde

I

were obtained from

was purchased from Qiagen,

Inc.

to a reported

a solution of final concentration of 5

pET-3b and pET-14b were purchased from Novagen,

EcoR

I,

H2O to give

All except

restriction

New England

mM.

enzymes

Biolabs.

Ni-NTA

Isopropyl-p-thiogalactoside (IPTG)

was used

as

received from Calbiochem. Centriprep 10 ultrafiltration units were obtained from Amicon
Division,

W.

R. Grace

Bangs Laboratories,

3.2.2

& Co.

Non-porous

silica

microspheres were purchased from

Inc.

DNA Construction

Plasmid pJK33 (obtained from Professor Frank Raushel of Texas

was digested with

BamH

the phosphotriesterase

I

was

and EcoR

I,

and the 1014 bp subcloned opd gene^^ encoding

isolated by agarose gel electrophoresis.

pUC18 by BamHI-EcoRI

prepared from

digestion

BamH I and purified by electrophoresis on a 1%
the linear

was

pET-3b was

a fragment designated opdl (Figure 3.1).

combined with

A&M University)

pET-3b fragment and

plasmids were used to transform bacterial

A 21

ligated with the

linearized

agarose

gel.

bp linker

opd gene

to yield

by digestion with

The opdl fragment was

the resulting population of recombinant

strain

HBIOI.

Colonies were selected and screened for insertion and orientation by digestion with

BamH

I

(supposed to yield fragments of 1035 bp and 4639 bp) and EcoR

yield fragments of 1524 and

4150

pOL-1) was digested with Nde

I

bp).

and T7 phage leader sequences was

pET-14b was

digested with

Nde

I

I

and the 2334 bp fragment containing the opdl

isolated

and Pst

(supposed to

resulting recombinant plasmid (designated

The

and Pst

I

I

by electrophoresis on a

1%

agarose

gel.

and the 3399 bp fragment ligated to the 2334

96

bp fragment prepared
coli strain

verified

as just described.

ligation mixture

BL21(DE3)pLysS. Transformants were

by digestion with Ava

final

the His-tag and

to transform E.

selected and plasmid

(designated pOL-2)

BamH I and treated with DNA

oiopd. The

was used

DNA was

(which yields fragments of 486, 1254 and 3993 bp).

I

The resulting expression plasmid
with

The

polymerase

was subjected

to partial digestion

BamH I

to destroy the

the

site at

3'

recombinant plasmid (pOL-3) encodes 40 additional amino acids

T7

tag fused at the N-terminal

Asn

end
(for

residue of the modified

phosphotriesterase reported by Mulbry and coworkers which involves deletion of the 33

N-terminal amino acids and replacement by the
Ser-) followed by the residues

Gly34 of the

3.2.3 Expression and Purification of

first

native

5 lac

Z residues (Met-Ile-Thr-Asn-

enzyme^ ^.

Recombinant Phosphotriesterase

Cells containing the recombinant plasmid were grown in 2

phosphate medium^^ supplemented with 0.5
0.8-1.0. Protein expression

culture reached

was iniuated with

mM. The

concentration of 0.4

OD600 ca.

mM C0CI2

1.5,

were resuspended

phosphate buffer

pH

in

8.0,

growth temperature was kept
corresponding

40 ml of ice-cold

300

37 °C

the addition of

to 4-5

of culture. Cells were harvested by centrifugation
pellets

at

until

IPTG

at

ODcoo reached

to a final

30 °C. After 4 hours, the

g of cells (wet

at

of rich tryptone-

liters

cell

weight) per

5,000 x g for 10 min

sonication buffer (50

at

liter

4 'C. Cell

mM sodium

mM NaCl, 0.1 mM C0CI2 and 0.1% Triton X-100) and

stored at -80°C overnight.

The frozen
and RNase
completely

bacterial cells

were thawed

at

37 °C for 90 min after addition of DNase

to a final concentration of 10 |ig/ml each. If cells didn't appear to be lysed

—

if

the solution

was not viscous—cell mixtures were then

5 second pulses for 10 min. The following steps were performed
lysate

was obtained

after centrifugation at 12,000 x g for
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at

sonicated on ice in

4 °C. Clear

cell

30 min. Saturated (NH)4S04

was added

to the lysate

dropwise

stirred for

60 min. The

solution

precipitate

The

was redissolved

protein solution

sonication buffer.

by centrifugation
i.d.).

in

to reach a final concentration of

was centrifuged

20 ml of sonication

was added

The mixture was

buffer.

ml Ni-NTA agarose

stirred gently for

resin, preequilibrated with

2 hours. The resin was collected

C0CI2, 10% glycerol,

pH

The

resin

was then washed

mM sodium phosphate buffer, 300 mM NaCl, 0.1 mM
Further washing was conducted with Tris buffer,

6.0).

cm

sonication buffer until no significant decrease in

detected in the eluent (approximately 100 ml).

with 80-100 ml wash buffer (50

7.9, containing

to 8

12,000 x g for 20 min, and the

5,000 x g for 5 min and packed into a polypropylene column (1.6

at

The column was washed with

OD280 could be

at

50%. The mixture was

low concentrations of imidazole: 50 ml

pH

MCAC-0 buffer (20 mM Tris Cl,

mM NaCl, 0.1 mM C0CI2), 50 ml MCAC-5 buffer (MCAC-0 buffer, 5 mM
imidazole), 50 ml MCAC-20 buffer (MCAC-0 buffer, 20 mM imidazole) and 10 ml of
MCAC-60 (MCAC-0 buffer, 60 mM imidazole).
pH 7.9, 500

The

target protein

was eluted with 4 x 3 ml MCAC-200

eluted in the 3rd fraction).

HEPES

buffer (50

The

eluent

was immediately

mM HEPES, pH 8.5,

Rad Econo-Pac lODG prepacked column

10%
(a

buffer (most target protein

subjected to buffer exchange into

mM C0CI2) using a Bio-

glycerol and 0.1

poly aery lamide-based size exclusion

column). The enzyme solution was further concentrated

to 0.6

mg/ml by

ultrafiltration

using a Centriprep 10 column. Proteins were analyzed by electrophoresis on

polyacrylamide
the Bradford

gel.

Quantitative measurements of protein concentration were

method with bovine serum albumin

12% SDSmade by

as standard^.

3.2.4 Immobilization Procedure

Non-porous

silica

under vacuum before

microspheres (0.8
use.

^m diameter)

were dried

at

Recombinant phosphotriesterase solution
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room temperature
(0.6

mg/ml

in

50

mM HEPES buffer, pH 8.5) was added

in a ratio

mg enzyme/g

of 6

suspension was mixed well with repeat peppeting and
incubated

at

beads.

The

4 °C overnight. The

mM HEPES buffer. pM 8.5, until no activity was

beads were washed extensively with 50

detected in the wash, and then resuspendcd

in

IlEPES

buffer.

The

extent of

immobilization was determined from the difference between the amount
of enzyme added
to the suspension

and the amount present

in the

wash

solution.

Protein adsorption

was

also determined from the difference in the enzymatic activities of the
incubation and wash
solutions.

3.2.5

Enzyme

Activity Measurements

For the soluble recombinant phosphotriestcrase, enzymatic
using paraoxon as the substrate

in

mM CUES buffer

150

activity

at pll 9.0.

was measured

The

reaction

monitored through the absorbance of the hydrolysis product /7-nitrophenolate

nm, e=17,000

cm

')'^.

The UV-vis absorption

Model 2600 spectrophotometer. One
that hydrolyzes

1

unit

(X,max

400

spectra were collected on a Hitachi

of activity

is

defined as the amount of enzyme

^imol of paraoxon per minute. For the immobilized phosphotriestcrase,

enzyme-treated beads were suspended
activity

was

was monitored through

in

150

mM CHES buffer, pH 9.0.
nm

Enzyme

the absorbance at

400

was measured

paraoxon concentrations ranging from

upon addition of substrate

paraoxon.

The

initial

0.025 to 1.5
equation,

V

reaction velocity

mM. The
=

kinetic constants

VmS / (Km +

S),

where

S the substrate concentration and
determined

in at least three

Km

V

for

were detemiined from the Michaelis-Menten
is

the initial velocity,

the Michaelis constant.

Vm
The

the

maximal

velocity,

kinetic constants

independent measurements, each using twelve paraoxon

concentrations.
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were

The

rate of

enzymatic hydrolysis of paraoxon

(1

mM)

soluble and immobilized forms of the phosphotriesterase

pH

value was adjusted with the following buffers (100

mM MES, pH 6.0;

4.0,

pH

100

mM CHES, pH 9.0 and

5.0;

100

100

100

was determined

pH

at

values from 4 to

1

1.

The

mM sodium acetate buffer, pH

mM MOPS, pH 7.0;

mM CAPS, pH

for both the

10.0,

pH

mM HEPES, pH 8.0;

100

11.0)

3.2.6 Stability Study

The

stability

examined via

of the immobilized and soluble forms of the phosphotriesterase were

activity

measurements using

was evaluated by incubating

9.0.

Thermal

150

mM CHES buffer, pH 9.0.

removed

at

stability

in

the

150

enzyme

at

mM CHES buffer, pH
55 "C for 60 minutes

in

Aliquots of enzyme solution or suspension were

10 minute intervals and activity was determined as described above. Stability

upon prolonged storage
paraoxon

mM paraoxon in

1

150

at

4 °C was also determined using 0.3

mM CHES buffer, pH 9.0.

collected, diluted with

50

At

of enzyme, 0.5

|J.g/ml

intervals of five to ten days aliquots

mM
were

mM HEPES buffer, pH 8.5, and assayed for enzymatic activity

as described above.

3.2.7 Activity

An

Upon Repeated Use

aliquot of the immobilized recombinant phosphotriesterase

diameter) was resuspended in 150

mM CHES buffer, pH 9.0, in the

(Fisher) centrifuge unit (0.2 ^im). Paraoxon (2.0
reaction, and the supernatant

was

mM)

was added

isolated after 5 seconds

absorbance of the supernatant was measured
filter

on

were resuspended and subjected

to the

at

glass beads (75 ^im

filter

of a Spin-X

to start the hydrolysis

by centrifugation. The

400 nm. The beads

isolated in the upper

same procedure through 10 cycles.
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3.3 Results and Discussion

and Purification of Recombinant Phosphotriesterase

3.3.1 Expression

A gene encoding a recombinant phosphotriesterase containing six consecutive
histidine residues at the N-terminus

was constructed and expressed

in Escherichia coli

under control of a T7 phage promoter^"^. Expression was visualized

by both Coomassie Blue
appeared

staining and western blotting methods.

in the lysate after

one hour of induction and continued

hours, as indicated by growth of a strong

(Figure 3.2a).

new

in

The
to

protein band at ca.

whole

cell lysates

target protein

accumulate for 4

SDS-PAGE

40 kDa on

A T7 phage derived sequence near the N-terminus allowed easy detection

of the target protein by western

blotting; observation of a single

band on the

blot,

indicating lack of C-terminal protein degradation (Figure 3.2b). Further analysis
that the

recombinant enzyme partitioned between soluble and insoluble (inclusion body)

fractions in the expression strain. Cells were

medium

to

reduce inclusion body

growth medium

to

by

ammonium

grown

formation'^-^,

improve the enzymatic

The recombinant enzyme was
lysate

showed

purified

and

30 "C

Co^"*" (0.5

in rich tryptone

mM)

phosphate

was included

in the

activity of the target protein^^

from the soluble

sulfate precipitation followed

agarose^^ (Table 3.1).

at

The homogeneity of the

whole

cell

by chromatography on Ni-NTA

protein

(Figure 3.3) and amino acid analysis (Table 3.2).

fraction of the

The

was

verified

by

SDS-PAGE

purified recombinant

phosphotriesterase (PTE) exhibited a specific activity of 5630 units/mg.

Phosphotriesterase from Pseudomonas diminuta has been expressed in E. coli
deletion of the 33 N-terminal

Thr-Asn-Ser-)
a yield of 298

at the

1

the

fu-st

5 lac

Z residues

with

(Met-Ile-

N-terminal glycine of the truncated enzyme'l. The authors reported

mg of protein

units/mg using

amino acids and fusion

,

from 160 g of bacterial

mM Co2+ in the growth medium.
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cells

In

and a specific

activity of

8020

our expression system, however,

the concentration of cobalt ion
toxic for

exceed

BL21(DE3) pLysS

0.8.

was

limited to 0.5

cells to

The decreased PTE

grow

efficiently

activity of our

concentration of Co2+ in the growth medium.

40 amino

mM;

1

mM or 0.75 mM Co2+ was too

and the optical density did not

system might be a result of the lower

It

could also be attributed to the additional

acid residues at N-terminus of the reported enzyme; the
recombinant

molar mass of 40,247 Da compared

to

34,524

Da

expressed in E.coli previously.

normalizing with molecular weight, the activity of the recombinant
the

enzyme

PTE

PTE

82%

is

has

If

of that of

previously reported. Nevertheless, the recombinant phosphotriesterase

remained highly enzymatically

active, with a specific activity of

5630 units/mg toward

hydrolysis of paraoxon.

3.3.2 Immobilization of

The

PTE on

Silica

Beads

purified recombinant phosphotriesterase

was immobilized on

silica

through

physical adsorption. Non-porous silica beads were used as solid support to reduce the

mass

transfer effect. Microspheres of 0.8 |J.m in diameter were chosen to provide

sufficient surface area for protein adsorption.

the microspheres yielding 34 units of

protein adsorbed on the

silica,

6

The enzyme was adsorbed

quantitatively to

enzyme per milligram of beads. The amount of

mg enzyme/g

coverage estimated from the dimension of the

beads, allows approximately monolayer
crystal structure of the

holoenzyme (50

A

in

diameter per subunit)'^.

The immobilized recombinant
units/mg, which

paraoxon

is

is

comparable

phosphotriesterase has a specific activity of 5200

to the value obtained for the soluble

used as the substrate (Table

for an immobilized

3.3).

This

is

enzyme when

the highest activity reported to date

form of the phosphotriesterase. Immobilization of the

phosphotriesterase has been reported previously by Caldwell and Raushel'^,
trityl

who

used

maximal activity
agarose to bind the enzyme through hydrophobic interaction. The
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of their system was
activity of

40%

of that of the soluble enzymes, which they
purified to a specifnIC

3200 units/mg^l Moreover,

enzyme was complicated by
addition of

the assay used for evaluation of the
immobilized

adsorption of the substrate on the hydrophobic
support, and

10% methanol was

required to reduce the affinity of substrate for the
agarose

matrix. In a control experiment, the immobilized
phosphotriesterase on silica
significant

change

in catalytic activity with inclusion of

buffer, indicating that silica as a matrix has

products. Methanol

is

little

10% methanol

showed no

in the reaction

or no affinity for the reaction substrate or

therefore not required for activity measurement in the system

reported here.

The molecular

interactions involved in adsorption of the phosphotriesterase

on

are likely to be complex. Electrostatic interactions between amino groups of the
(NHs"'')

and dissociated

silanol (SiO') groups of silica

recombinant phosphotriesterase was immobilized up
buffers with

pH from 5

100%) compared

to

1 1

seem

to

silica

enzyme

be involved. The

to

98% on

silica

when

incubated in

(Table 3.4), displaying varied relative activity (40% to

to the soluble form.

value of 13 and greater, only about

However, when incubated

5%

at buffers

with

pH

of the enzyme was adsorbed.

Analysis of the crystal structure of the phosphotriesterase reveals 10-16 basic groups
(lysine

and arginine) on

the surface of the

recombinant phosphotriesterase
13,

which

is

is

enzyme^ ^. The

calculated to be 8.7.

isoelectric point of the

When

incubated in a buffer

above pKa values of the lysine and arginine, the enzyme should have few

positive charges

on

the surface and therefore

little

protein adsorption occurs under such

conditions. Ionic interactions are found in other immobilized proteins on glass.

been reported
protein.

On

that the rate of initial protein adsorption

The higher

force for recombinant
is

It

has

depends on surface charge of the

the isoelectric point of the protein, the higher the adsorption rate^^.

the other hand, ionic interaction of

enzyme

pH

at

enzyme

also likely involved.

amino and

adsorption.

silicate

groups seems not to be the only

Hydrogen bonding between

silanol

High ionic strength buffer solutions (NaCl up
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and the
to 2

M)

were not able

to elute the phosphotriesterase

from

silica in detectable quantity.

The

additional six N-terminal histidine residues on the recombinant
phosphotriesterase

may

also play a significant role in the hydrogen bonding, especially
considering that they are

on the outer surface of the protein compared

likely to be accessible

enzyme^ ^ Hydrophobic

histidines in the native

as protein adsorption

surfactant Triton

was

X-100

was observed when up

interactions

not affected with addition of up to

in the incubation buffer.

to

4%

of the surfactants

No

SDS

seem

2%

to the seven other

to be less significant,

of the nonionic

significant desorption of the

or Triton

enzyme

X-100 were included

in

the elution buffer.

The

phosphotriesterase has been

shown

host microorganism Flavobacterium sp^^.

to be a

membrane-associated enzyme

The enzyme

is

in the

expressed as a precursor with

365 amino acid residues and

is

which 29 amino acids

N-terminus are removed to give the mature form^^. For

cloning in E.

coli,

at the

processed through a post-translational modification

Mulbry and coworkers deleted

immobilized on

silica

the active

on

site.

exhibits activity similar to that of soluble form.

enzyme on

The immobilized

the activity of the

phosphotriesterase

might provide information on the native membrane-bound enzyme.

The immobilized enzyme
the orientation of the

the leader sequence in order to yield the

The recombinant

soluble and enzymatically active protein

in

enzyme

the silica surface that maintains

It

suggests that

maximal preservation of

phosphotriesterase on silica might provide

some

insight

in vivo.

3.3.3 Kinetic Study

Kinetic study of the soluble recombinant phosphotriesterase shows that the

enzyme

plots
follows Michaelis-Menten kinetics, giving a linear correlation on Lineweaver-Burk

(Figure 3.4).

The recombinant enzyme

catalytic rate constant (kcaO of

catalyzed hydrolysis of paraoxon resulting in a

3880 ± 310

s

'

(Table 3.3). The additional His-tag didn't
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significantly affect the enzymatic activity; the recombinant
phosphotriesterase activity is

comparable

to that of the bacterial phosphotriesterase

The immobilized
form, as shown

from Pseudomonas diminuta^^.

phosphotriesterase exhibits kinetics similar to those of the soluble

in the linear

Lineweaver-Burk plots (Figure

mM-1 mM). The

paraoxon concentrations (0.025

3.4) over a

wide range of

kinetic constants of the immobilized

phosphotriesterase were determined (Table 3.3). The kcai value of the immobilized

phosphotriesterase

is

3490 ± 500

s

^ comparable

to that of the soluble

value of the immobilized phosphotriesterase, however,

A

soluble enzyme.

immobilized on

similar increase in

trityl

agarose^ ^.

internal diffusion effects
to the

Km

is

was reported

The higher

enzyme. The

Km

3-4 times higher than that of the

for the phosphotriesterase

Km value might be due to external and

upon immobilization^^. The mass

immobilized phosphotriesterase could be very

transfer effect of the substrate

significant, considering the rate

determining step for catalytic hydrolysis of paraoxon

in solution

was

the diffusion

limit29.

The
from 4

activity of the

to 11, as

shown

narrower optimal
8 and 9.

The pH

the soluble

immobilized phosphotriesterase was determined

pH

in

pH

range

Figure 3.5. The immobilized phosphotriesterase has a

range than the soluble enzyme, giving maximal activity between

profile of the

enzyme from pH 4

showed lower relative

enzyme from

in the

immobilized phosphotriesterase
to 9. In the higher

pH

is

comparable with

region, the immobilized

activity than the soluble system, possibly

due

pH

that

of

enzyme

to desorption

of the

silica.

3.3.4 Stability of the Immobilized Phosphotriesterase

One

of the most frequently cited advantages of immobilized enzymes

stability^^.

It

is

improved

support, enzymes
has been suggested that through confinement on a solid

should be more likely to

resist

conformational changes and thus exhibit higher
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stability

than soluble enzymes. In our studies, enzymatic activity
was tested

at

elevated

temperature, after prolonged storage time and after dilution
with buffer. The stability of
the immobilized phosphotriesterase under such conditions

was compared with

of the

that

soluble enzyme.

Thermal

3.3.4.1

When

stability

incubated

at

55 °C, the soluble enzyme showed a

30 minutes and retained only 20% of

On

its

distinct loss

original activity after

of activity within

60 minutes (Figure

3.6).

the other hand, the activity of the immobilized phosphotriesterase remained constant

over a period of 60 minutes
phosphotriesterase

is

more

at

55 °C. This result indicated

stable than the soluble

3.3.4.2 Storage Stability

While stored

at

enzyme

that the

at

immobilized

elevated temperature.

•

4 °C, both the soluble and the immobilized forms of the

phosphotriesterase showed good stability for up to 20 days. Less than
activity

was

soluble

enzyme was reduced

retained

lost

84%

during this time. After storage for 32 days

of its

to

65%

initial activity

of

its initial

(Figure 3.7).

at

4 °C, the

these measurements the immobilized

prolonged storage

3.3.4.3 Stability

The

When

at

4 °C than the soluble

Upon

The

activities

enzyme

exhibited

initial

activity of the

enzyme

of both the soluble and the

more

to 8

stability

months.
during

protein.

Dilution

soluble phosphotriesterase

the soluble

of

value, while the immobilized

immobilized enzyme remained approximately constant thereafter for up

From

5%

enzyme was

showed

significant loss of activity

diluted 5-fold from an
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initial

upon

dilution.

concentration of 0.6

mg/ml

with

HEPES

buffer, only

25%

of the expected activity was observed
(Figure

Further dilution resulted in loss of activity to a level
of 10
phosphotriesterase was determined to be a
structure'5. Dilution of the

enzyme

% of the original value.

homodimer from

in solution

result in formation of enzymatically inactive

may

the X-ray study of

was

monomer. Another possible reason

insensitive to dilution.

immobilized enzyme remained constant up

its

to

The
crystal

cause dissociation of the dimer and

a decrease could be the partial unfolding of the enzyme upon
dilution.
the immobilized phosphotriesterase

3.8).

20 fold

The

the other hand,

activity of the

Such a

dilution.

On

for such

result indicated that

the recombinant phosphotriesterase gained dimensional stability upon immobilization
and

was much

easier to handle in a variety of concentrations

3.3.5 Activity of Immobilized Phosphotriesterase

One

compared with

Upon Repeated Use

of the advantages of an immobilized enzyme

is its

ease of separation from the

reaction products and compatibility with continuous processes.
to determine the activity of the

immobilized phosphotriesterase

In addition, since the recombinant

enzyme

adsorption instead of chemical bonding,
activity

is

really

is

it is

the soluble form.

It is

therefore important

in multiple cycles

of use.

immobilized on a surface through physical
necessary to verify whether the measured

from the immobilized enzyme or from

the desorbed soluble

enzyme

during reaction. The activity of the immobilized phosphotriesterase was measured
sequentially through 10 cycles of use (see Figure 3.9).

depressed to approximately

80%

the activity remained constant.

enzyme
first

few

of

The

its initial

initial

relative activity

value during the

decrease

desorption, as increases of absorbance
eluents.

The

in activity

at 4(X)

first

was

three cycles; thereafter

may have been

nm over time

a result of

were observed

in the

However, the immobilized recombinant phosphotriesterase preserved a

majority of the enzymatic activity in repetitive uses. This suggests that the immobilized

enzyme

is

a good candidate for used in continuous devices.
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.

3.4 Conclusions

A recombinant

bacterial phosphotriesterase

(PTE) bearing an N-terminal hexahistidine

sequence was constructed through genetic engineering and expressed
control of a

T7 phage promoter. The

recombinant enzyme by metal chelate

in E. coli

hexahistidine tag allows purification of the

affinity

chromatography. The recombinant enzyme

followed Michaelis-Menten kinetics with a catalytic rate constant of 3880
hydrolysis of paraoxon.

The

activity of

under

recombinant

PTE was shown

to

±310

be

82%

s

'

for

of that

reported for the bacterial phosphotriesterase, as calculated by normalization of the

molecular weights of the two proteins.

The recombinant

phosphotriesterase

was immobilized on non-porous

silica

microspheres by simple physical adsorption. The optimal amount of enzyme adsorbed
this

system was 34 units of enzyme

coverage.

The

activity per

was

protein-surface interaction

mg of support,

in

yielding near monolayer

attributed to a combination of ionic and

hydrogen bonding. Like the soluble form of the enzyme, the immobilized
phosphotriesterase followed Michaelis-Menten kinetics, with a catalytic rate constant of

3490 ± 500

s-'.

The Michaelis

enzyme, possibly due

constant

to the external

Km

and

internal diffusion effects

The immobilized enzyme has been shown
and sample handling compare

upon repeated

was 3-4 times higher than

upon immobilization.

to exhibit higher stability

to the soluble

fomi of the

protein.

that of the soluble

It

towards heat, storage

remains highly active

use.

The immobilized recombinant

phosphotriesterase, by virtue of

its

ease of preparation,

high catalytic activity and broad substrate range, offers good potential for the

development of biosensors and column reactors
organophosphorus pesticides and nerve agents.
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for rapid detection

and detoxification of
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Table

3.1 Purification of

Fraction

recombinant phospholrieslcrase

Total protein

Total activity

Specific

Yield

Purification

units/ m}i

%

fold

activity

units

X

I (y^

576

4.33

74.8

100

1

sulfate ppt

248

4.56

184

105

2.4

Ni-NTA

2.3

1.30

5630

30.0

75

Cell lysate"

Ammonium

a Isolated

from 2

liters

of culture grown to ODf^)o = 1.59 (4.5 g/L wet

Ill

cell weight).

Table 3.2

Amino

acid composition of the recombinant phosphotriesterase^

/\I111I1U <ICIU

rredictcci'^

Analysis^

Ala

10.7

Uiy

o o

Cjlx(Ulu+01n)
Asx(AspH-Asn)
r ne
I Ho

7.5
7.3
/I
4.U

9.9
10.2
7.3
6.3
3.9
^ /I
3.4

He
Lys
Leu
Met

6.7
2.1
9.1
2.4

Pro

Arg

4.6
7.8

Ser

9.1

Cys

0.5
6.7
6.4

<0.03

1.3

1.2

Thr
Val

Tyr
Trp

^Determined

5.5
1.9

8.5
2.9
5.8
8.4
10.8
6.1

5.9

1.1

in

niol%

^'Deduced from the

DNA sequence encoding the proceeding protein

^Values were obtained by calculations based on molecular weight of 40247,
derived from amino acid sequence.

^ND: not determined
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Table 3.3 Kinetic constants of soluble and immobilized recombinant phosphotriesterase^

Km (m)

Specific activity

kcat (sec

-i)

kcat /

Km

(units/mg)

(10 7 M-^

Soluble

Immobilized
"

The

5630

150

±50

3880 ±310

2.6

5200

480 ± 90

3490 ± 500

0.7

s-1)

purified phosphotriesterase has been reported^^ to exhibit specific activities of

3200-8020 units/mg,

Km

130

and

kcat

4870

113

sec'l.

Table 3.4 Immobilization of phosphotriesterase on

pH

5.3

silica at different

pH values'*

6.8

8.5

11

>13

100

99.9

98

5.3

39

92

104

4

Enzyme
adsorbedb(%)
Relative activity^

64

(%)
^Phosphotriesterase was incubated with silica microspheres
protein

/

g

silica.

Enzymatic

activity

was determined

^Enzyme adsorption was determined from

in a

at

150

a concentration of 6

mg

mM CHES buffer, pH 9.0,

the enzymatic activity difference between the

incubated beads and the wash solution.
^Relative activity

is

the ratio of reaction rate of the immobilized

amount of soluble enzyme

for hydrolysis of

1

mM paraoxon.
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enzyme

to that of the

same

Cut E,

B

E
opd

U

1014 bp

1.

2.

Linker
T4 Ligase

Linker;
5'

3'

BamHI
gatccccgggtaccgagctcg
gggcccatggctcgagcttaa

EcoRI

B

Enzvmes:
E EcoR I, B - BamH I
N-Ndel, P-PstI
Restriction

N
Cut

N,P

Cut

T4 Ligase

1.

Partial digestion with

2.

DNA

3.

T4 ligase

polymerase

N

(B)

Figure 3.1

BamHI

DNA Diagram of construction of recombinant phosphotriesterase

115

N

1

2

3

4

5

6

2

1

3

97kD£^

45

6

-.•'1
; .

t.'.

kDa-

^'^^j'jirfwv.

31

5

v^-^><^- ^-*^-:

;S(.r^>,!v*:;;

.
-

4

>t««n«^

kDa-

(a)

Figure 3.2

SDS-PAGE

analysis of expression of the recombinant phosphotriesterase in

E. coli strain
after

IPTG

(b)

BL21(DE3)pLysS. Shown

as

whole

cell lysates at intervals

induction, (a) Gel stained with Coomassie Blue, (b) Western blot

with monoclone T7 antibody. Lane
to bottom, 97.4,

1,

molecular weight markers (from top

45 and 31 kDa); lanes 2

hours after induction, respectively.
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-

6: cell lysates at 0, 1, 2,

3 and 4

2

1

Figure 3.3

3

4

5

SDS-PAGE of purification of the recombinant phosphotriesterase.

Lane

1,

molecular weight markers (from top to bottom, 97.4, 45 and 31 kDa); Lane
2: cell supernatant;

lane 3: protein precipitated from

lane 4: eluted fraction from

containing 60

Ni-NTA column

50% ammonium

sulfate;

with sonication buffer

mM imidazole; lane 5 and 6: two fractions of eluent from

buffer containing

200

mM imidazole.
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500

n

0008

0.016

0.024

0.032

0.04

l/[Paraoxon] (jiM-i)

Figure 3.4 Lineweaver-Burk plots for the soluble (0) and immobilized (•) recombinant

phosphotriesterase.
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Figure 3.5

pH

profiles of the soluble (0)

and immobilized (•) recombinant

phosphotriesterase in the hydrolysis of paraoxon (1

119

mM).

Figure 3.6 Thermal

stability

of the soluble (0) and immobilized (•) recombinant

phosphotriesterase at 55

120

100

o
80

t5

<

60

<u

'I

40

20

0

L_i_i_L

0

J

50

100

stability at

I

I

I

150

Time

Figure 3.7 Storage

I

I

I

L

200

250

(days)

4 °C for soluble (0) and immobilized (•) recombinant

phosphotriesterase.
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Figure 3.8 Activity of soluble (0) and immobilized (•) recombinant phosphotriesterase

for hydrolyzing paraoxon

when

diluted with

122

50

mM HEPES buffer, pH 8.5.

100

80

-

60

-

40

-

20

-

<

0^

0
4

6

8

10

Cycles of use

Figure 3.9 Activity of immobilized phosphotriesterase upon repeated use
hydrolysis of paraoxon.
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CHAPTER 4

DETERMINATION OF ORGANOPHOSPHATE PESTICIDES BY CONTINUOUS

FLOW BIOSENSORS

4.1 Introduction

Organophosphate pesticides have been widely used
their high effectiveness.

However,

their use also causes

their acute toxicity as cholinesterase inhibitors^

toxic

by

all

in

developed countries because of

environmental concerns due to

Organophosphorus pesticides are highly

routes of exposure including ingestion, dermal absorption and inhalation^.

Severe poisoning can affect the central nervous system, producing lack of coordination,
slurred speech, loss of reflexes, weakness and fatigue. Repeated and prolonged

exposure to organophosphates

may

disorientation, severe depression

result in

and speech

symptoms such

ground water and

method such

with such methods

at

as

mass

versatile

low

detectors, with confirmation of results using an

parts per million

injection analysis (FIA)^

and simple

soil,

spectroscopy"*. Residue concentrations can be determined

however, the required instrumentation

Flow

environment including

most pesticide residue determination has been performed by gas

chromatography with element-selective
ancillary

in the

and rapid detection methods are therefore of great

vegetation-^,

interests. Currentiy,

memory,

Contamination by residual

difficulties.

organophosphate pesticides has been found widely

as impaired

to operate.

is

Over

is

(ppm)

to parts per billion (ppb) levels;

expensive and the analysis

a continuous flow

method

the past fifteen years,

is

time-consuming.

that is fast, accurate,

FIA techniques

for automatic

Flow
on-line sample analysis and monitoring have drawn widespread research interest^.
injection analysis based

on biological systems such as enzymes or antibodies provide

advantages of specificity and

sensitivity,

and have been a very active
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field

of

research''.

Only a few

biologically based systems have been developed for
organophosphate

pesticide detection, as

few enzymes or antibodies recognize

the synthetic

organophosphates. Inhibition of acetylcholinesterase has been used with
potentiometric
or amperometric detection for organophosphate pesticide determination via
decrease of

enzymatic activity

^,

with detection limits as low as 30 ng/ml

This measurement has

.

several drawbacks, including the use for two sample injections (inhibitor and substrate)

and the requirement for reactivation of the enzyme

The

phosphotriesterase from

reactor.

Pseudomonas diminuta hydrolyzes

a wide variety of

organophosphates including some of the most commonly used organophosphate
pesticides and deadly nerve agents^. Crystal structure analysis

consists of a

pH and

homodimer of 39 kDa

subunits^^.

temperature, and the catalytic

and coworkers'^'

The

The enzyme

mechanism has been

natural substrates of the

is

shows

that the

stable over broad range of

studied extensively by Raushel

enzyme

are not

known. Paraoxon

(diethyl-/7-nitrophenyl phosphate), an active metabolite of parathion (a

organophosphate pesticide),
diffusion

limit'-^.

is

hydrolyzed by the phosphotriesterase

Hydrolysis of paraoxon, as shown

O

enzyme

in the

commonly used

at rate

near the

following reaction,

O

EtO-P-0-HQ>—NO2

EtO-P-O"
^

OEt

+

"0-Q)-N02

OEt

produces a brightly colored phenolic product with an extinction coefficient of 17,000

M-^cm"^

at

400 nm^, which can be detected

quantitatively by

UV-vis spectrophotometry.

We reported recently a recombinant phosphotriesterase (PTE) that was expressed in
Escherichia coli and purified by immobilized metal affinity chromatography'"^. The

recombinant enzyme catalyzed hydrolysis of paraoxon with a reaction

rate similar to that

on nonof the native enzyme from Pseudomonas diminuta, and could be immobilized
porous

silica

microspheres through simple physical adsorption. The immobilized

125

^
phosphotriesterase showed specific activity comparable to
that of the soluble enzyme, and

followed the same Michaelis-Menten kinetics with a turnover
number of 3490
It

± 500

s'l.

exhibited higher stability towards heat, storage and sample
handling compare to the

soluble form of the protein.

including
activity

its

The immobilized

phosphotriesterase has

many

advantages,

direct determination of pesticides, ease of preparation, exceptionally
high

and broad substrate range. Here we wish

of the immobilized phosphotriesterase

system for the

sensitive, selective

to report, for the first time, application

to the construction of a continuous-flow injection

and rapid detection of paraoxon.

4.2 Experimental Section

4.2.1

Equipment

A Perkin-Elmer Lambda 3 UV-vis spectrophotometer was furnished with a cm (18
1

(ll)

path length flow cell (Pye Unicam) and equipped with a Hewlett-Packard 3394A

integrator.

An

Ismater Ms-Reglo variable speed peristaltic

to control flow rate.

A

pump

six-port Teflon rotary valve (Omnifit,

as an injector. All unions and end fittings were

made from

(PEEK) (Upchurch, Oak Harbor, WA). Tubing was

0.8

(Ismater

New

York,

SA) was used

NY) was

used

poly(ether ether ketone)

mm

i.d.

Teflon from Omnifit.

4.2 2 Reagents and Solutions

[N-2-hydroxylethylpiperazinel-N-2-ethanesulfonic acid (HEPES), 2-[N-

cyclohexylaminojethanesulfonic acid (CHES), and paraoxon were purchased from Sigma

HEPES

Chemical Company.
and 0.1

mM C0CI2.

buffer contained 50

mM HEPES, pH 8.5, 2% glycerol,

Paraoxon was purified by dissolution

by extraction with 10

in

dichloromethane following

mM CHES buffer, pH 9.0 according to a reported procedure^
126

The

purified paraoxon

was dissolved

in

water

in a final

stored at 4 'C. Recombinant phosphotriesterase

immobilized metal

affinity

final concentration

of 0.6 g/ml

"C

in

200

^il

aliquots.

The

in

is

at saturating

enzyme was determined

at

solution

was added

overnight.

The beads were washed extensively with 50

activity

was detected

from the difference between

in the

1

in a ratio

before

of 85 units of

well and incubated

at

4 °C

mM HEPES buffer, pH 8.5,

wash. The extent of immobilization was determined

the activity incubated with the beads and that in the wash.

The immobilized enzyme was packed

cm

be 5630

room temperature under vacuum

gram of beads. The suspension was mixed

X 2

to

concentration of the substrate.

activity per

no

to a

Immobilization

The recombinant phosphotriesterase

until

and purified by

defined as the amount of enzyme that hydrolyzes

Glass beads (75 |im diameter) were dried
use.

in £. coli

mM HEPES buffer, pH 8.5 and stored frozen at -80

50

specific activity of the

|imol of paraoxon per minute

Enzyme

was expressed

mM and

chromatography'! The purified enzyme was adjusted

units/mg, where one unit of activity

4.2.3

concentration of 0.5

into polypropylene tubes of dimension 2

mm (i.d.)

for use in FIA.

4.2.4 Manifold and Procedure

The flow

(HEPES

injection system

buffer)

4 ml/min.

An

is

was pumped by

shown schematically
a peristaltic

aliquot of paraoxon solution in

pump

at

HEPES

in

Figure 4.1. The carrier solution

steady flow rate in the range of 0.2buffer

was

injected upstream of the

immobilized phosphotriesterase column where the substrate was hydrolyzed
nitrophenolate.

The

to p-

hydrolysis products were passed through the flow cell and the

127

absorbance was read continuously

400 nm. Peak height and peak area were

at

determined by the calibrator and correlated with the paraoxon
concentration

An Environmental

Protection

Agency (EPA)

standard procedure

sample extraction. Soil samples were obtained from
at

sample.

Sample Extraction

4.2.5 Soil

oven

in the

105 'C. The dried

free soil sample.

soil

was sieved through

Two portions of approximately

farm and dried

a local

a 2

was used

for soil

in a

vacuum

mm mesh sieve to obtain a rock-

50 g of

soil

were weighted and spiked

with 0.5 ml of paraoxon stock solution (1.25 mg/ml). Acetone (40 ml) was added to

each sample and the mixture was shaken vigorously

added and the samples were shaken
allowed to
extraction

settle

for

20 minutes. Ilexane (80 ml) was

for an additional 10 minutes.

and the solvent was decanted

into a

liter

1

The samples were

separatory funnel.

The

was repeated with 20 ml acetone (20 minutes), followed by 80 ml of hexane

extraction (10 minutes).

The

extracts

were combined and back-extracted with

distilled

deionized water (5(X) ml) with gentle mixing. The organic layer was collected, combined
with an additional 25 ml of hexane extract of the aqueous

through a column of sodium

sulfate.

The organic

evaporation under reduced pressure and dissolved
diluted 20-fold with

I

lEPES

extract

in

.solution,

and then passed

was concentrated by

rotary

acetone (10 ml). The sample was

buffer and analyzed by FIA.

4.3 Results and Discussion

Immobilization of the recombinant phosphotriesterase on glass beads yielded near

monolayer coverage,

as estimated

from the dimensions of the enzyme'^. The column

phosphotriesterase
reactor used in the flow injection device incorporated 17 units of
activity.

The

carrier buffer

was 50

mM IlEPES, pi
128

I

8.5, in

which the immobilized

enzyme has been shown

to maintain optimal activity for periods
in excess of 6

months^l

Spectrophotometric determination of paraoxon was
achieved by the measurement of the

absorbance peak height and peak area of the hydrolyzed
product p-nitrophenolic ion

400 nm. As shown
12.5 [Lg/m\ to

in figure 4.2, triplicate injection of

75 ng/ml

(within

4.3.1

5%

paraoxon samples ranging from

results in incremental increases of the recorded

increasing paraoxon concentration.

standard deviations)

at

at

The measurement showed good

peak area with

reproducibility

each concentration.

Improvements of Variables

The following

variables affecting the performance of the system are studied for

determination of paraoxon concentrations

4.3.1.1 Variation of

The flow

in

aqueous solution.

Flow Rate

rate has a dramatic influence

on the performance of the system. Flow

ranging from 0.32 to 3.8 ml/min were studied
(Figure 4.3).

It is

shown

Lower flow rate results

that

at

rates

various concentrations of paraoxon

absorbance peak area increases with decreased flow

in longer residence times of the analyte in the

enzyme

rate.

reactor and

therefore higher extents of hydrolysis; a further increase in area at low flow rate arises

from the longer residence time of

the product

of the absorbance peak was shown

from 2 ml/min
a bit

to 0.5 ml/min.

more complicated

rates ranging

from 0.32

The

to increase 3-4 times

in the detector cell.

when

The

area

the flow rate decreased

trend for the absorbance peak height with flow rate

(Figure 4.4).
to 1.7

chromophore

When

paraoxon was injected

at

25 )ig/ml,

at

is

flow

ml/min, the peak height increased with lower flow rate

which could be

attributed to formation of

lower flow rate

result

more hydrolysis product

.

The broader peaks

from the longer residence time of the chromophore
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in the

flow

at

cell.

It is

observed that the peak heights

at

0.32 and 0.48 ml/min didn't seem to be

significantly different, suggesting complete hydrolysis
of paraoxon.

At high flow

rate

range (1.7-3.2 ml/min), however, the absorbance peak height
decreases with decreased

flow

rate.

The absorbance peak

height reflects the concentration of p-nitrophenolate in

the flow cell, while the peak area integrates the absorbance
with time in the flow cell. In

the high flow rate range, lower flow rate could result in dilution
of the chromophore in

the detector cell; and there are not significant increases in extent of hydrolysis
to offset the
dilution. Furthermore, decreases in flow rate result in loss of sampling
frequency.

A

flow rate of 0.5 ml/min was selected for determination of low concentrations of paraoxon
at

a sample rate of at least 20 per hour.

4.3.1.2 Variation of Injection

The volume of sample

Volume

injection

is

another important factor that affects FIA

performance. Larger injection volumes give more sensitivity as more sample

On

for hydrolysis.

the other hand, increasing injection

jil

to

500

\i\

were

tested.

As shown

testing.

in figure 4.5, the area

absorbance increases six-fold when injection volume changes from 50

4.3.

1

.3

|il

that

Injection

of under the
to

500

)il.

Variation of Manifold Length

The
is

available

volume gives broader peaks

could affect detection accuracy and decrease the frequency of sample

volumes of 50

is

overall manifold length

was

varied from

40

cm

to

100 cm. The manifold length

important for dispersion of the sample and sampling frequency.

We found an overall

increase of four fold in the detection signal with a 2.5 fold reduction

from 100

cm

to

40 cm.

A

manifold length of 40

130

cm was

in

manifold length

selected for measurements.

4.3.2 Paraoxon Analysis

A calibration curve was prepared by using selected values of the variables stated in the
previous section.

We used both 50

[i\

and 500

|il

injection

volumes and compared

detection limits achieved and the relative standard deviations of the measurement.

Solutions of paraoxon at concentrations between 25 ng/ml and 25000 ng/ml were injected
in triplicate.

correlation

As summarized

in

Table

1,

when 50

|il

sample was injected, a linear

was obtained between 125 ng/ml and 25000 ng/ml paraoxon, with an

regression coefficient (Figure 4.6).

The

detection limit

frequency under optimal conditions was 32 per hour.
increased 500

}il,

the linear determination range

was 25 ng/ml. The sampling

When

A paraoxon

is

was extended from 25 ng/ml

at the

while the pesticide laboratory using

± 0.8

25000

the other hand,

|ig/ml.

EPA

certified

Massachusetts Pesticide

University of Massachusetts and the concentration was

determined by our flow injection technique.

reported 20.9

On

to

decreased to 24 per hour.

sample was obtained from the

Analysis Laboratory

volume was

the injection

ng/ml paraoxon and a detection limit of 5 ng/ml was achieved.

sampling frequency

excellent

The two

We obtained a value of

±

19.7

1.2 |ig/ml,

GC analysis with flame photometric detection,
results are in

good agreement and

validate the

application of flow injection analysis for determination of paraoxon.

The immobilized

90%

activity for

phosphotriesterase reactor was stable with retention of more than

one month under repeated

use. Previous studies of the stability of the

immobilized phosphotriesterase have shown the enzyme
activity for

up

to 8

months of storage

at

4 °C.
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to maintain

80%

of its

initial

4.3.3 Determination of Paraoxon in Soil Samples

Soil samples

were selected

to study the validity of the proposed

method

determining organophosphate pesticide residues in environmental samples.
(50 g) was spiked with 625

^ig (12.5

into 10

ml of acetone. Acetone

buffer,

pH

added

8.5 for

FIA

analysis.

The

The FIA method

the pesticide

were diluted 20-fold with 50

solutions

to blank solutions prepared

added.

ppm) of paraoxon and

calibration curve

in order to get higher

method

is in

gives 286

±2\ig paraoxon,

yielding

46%

the Pesticide Laboratory using

49%. Although

mM HEPES

recovery of pesticide.

GC with flame
GC

method was 309

sample recovery, the pesticide determined by the proposed FIA

good agreement with

procedure was a standard
soil extraction

background of the

extracted

the extraction procedure needs to be improved

the

EPA standard

complicated by the high background of the blank

develop a

was

was constructed from paraoxon

photometric detector. The amount of paraoxon determined by the
yielding recovery of

A soil sample

by the same extraction method without paraoxon

The sample was cross-checked by

|J,g,

in

soil

soil

method. However, the result was
samples. Since the extraction

EPA method for GC analysis,

method

that is

more

further study

suitable for the proposed

is

necessary to

FIA method. The

blank could be reduced by cleaning up die extracted sample,

and/or by using a different solvent for extraction. Nevertheless, preliminary results from
soil

samples demonstrated the applicability of the flow

injection

immobilized phosphotriesterase reactor for pesticide detection

132

in

method using an
environmental samples.

4,4 Conclusions

For the

first

time, a direct photometric

method using a flow

proposed for the detection of organophosphate

pesticides.

hydrolysis of pesticide by a highly active immobilized

hydrolysis product which

spectroscopy.

is

injection biosensor is

The method

enzyme

is

based on

reactor, yielding a

quantitatively determined by electronic absorption

The advantages of the proposed method

are: (1) simplicity

—

the

method

requires a single line manifold system, and the absorption measurement of the detected
signal

is directly

limit of 5

proportional to the sample concentration; (2) sensitivity

ng/ml was achieved by the proposed method, which

current standard

GC method;

(3) specificity

phosphotriesterase can be detected.

As

the

is

—only substances

enzyme hydrolyzes

organophosphate pesticides, the proposed method
substrates besides paraoxon; and (4) economical

is

expected

—due

—

a detection

comparable with the

that are substrates for the

a variety of
to

determine other pesticide

to the simplicity

of the proposed

method, determination of paraoxon can be achieved with most existing flow
instrumentation with high sample throughput.
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4.

1

Features of the method

500

Injection

50

^ll

^il

volume
A=(2.76±0.14 )xlO^

Equation"
Regression

[PI

+ 4.82x104

0.99927

A=(5860±130)

[Pl

+ 4.14xl04

0.99935

coefficient

Linear range''
Detection

limit''

Quantitative

R.S.D

%

limit''

25-25000
5

25

25

125

0.7-5.8

A = area of absorbance at 400 nm,
''

125-25000

[PI

0.7-7.5

= paraoxon concentration (ng/ml)

ng/ml
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Figure 4.1 Flow injection manifold for determination of organophosphate pesticides:
Carrier stream;

P=

peristaltic

spectrophotometric detector;
reactor

is

pump;

I

=

injection valve;

C

D=

W = Waste; and R = Recorder.

The enzyme

constructed from immobilized phosphotriesterase on glass beads

(75 |im diameter).
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I

1

1

Min.

Figure 4.2 Spectrophotometric determination of paraoxon by flow injection analysis.

The concentrations of paraoxon
|ig/ml and (d)
8.5.

The

75

|ig/ml.

injection

The

are (a) 12.5 |ig/ml, (b) 25 |ig/ml, (c)

carrier stream

volume was 50

hour.

137

^il,

was 50

sampling

rate

50

mM HEPES buffer, pH
approximately 150 per

2

10%

0

0.5

1

1.5

2

Flow

rate

2.5

3

3.5

4

(ml/min)

Figure 4.3 Effect of flow rate on the area of absorbance peaks

at

paraoxon concentrations

of 25 llg/ml, 12.5 |lg/ml and 5.0 [ig/mi. The injection volume was 50

138

|J.l.

Figure 4.4 Effect of flow rate on absorbance
^ig/ml in 50

mM HEPES, pH 8.5.

at

400

nm

The flow

for hydrolysis of paraoxon of 25
rates are: 1=3.8 ml/min;

2=3.2

ml/min; 3=2.8 ml/min; 4=2.2 ml/min; 5=1.7 ml/min; 6=1.1 ml/min; 7=0.5

ml/min and 8=0.32 ml/min.
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Figure 4.5 Variation of peak area with sample injection volume. Paraoxon concentration
is

12.5 |ig/ml, flow rate 0.5 ml/min.

140

[Paraoxon] (ng/ml)

Figure 4.6 Calibration curves for paraoxon with samples ranging from 25
using the flow injection device. Samples
in triplicate.
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at

to

25000 ng/ml

each concentration were injected
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